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ABSTRACT 
This study examined the effects of two different frequencies of 
Transcutaneous Electrical Nerve Stimulation (TENS) on chronically 
painful and stiff osteoarthritic knees. The effects studied were 
changes in pain state, changes in stiffness state, changes in 
circumference, and changes in range of movement. 
Three groups, each of 20 subjects, were given a single 30 minute 
application of TENS: the first group received High Rate (Conventional) 
TENS, the second group received strong Burst Mode (Low Rate) TENS, and 
the third (control) group received a placebo application using the 
same active TENS with nonfunctioning leads. Each TENS frequency was 
applied for the same length of time, at tolerable intensities, to 
the same four acupuncture points around the knee. 
Measurements of joint pain and stiffness using Absolute Visual 
Analogue Scales were made immediately before and after the TENS 
application. Objective measurements of joint circumference and range 
of movement were also made immediately before and after the test, 
using a tape measure and goniometer respectively. The length of time 
the post-test pain and stiffness relief lasted was determined by the 
subject reporting when his "normal" pain and stiffness returned. 
These reports were collected 24 hours after the test. 
The aim of the experiment was to establish the hypothesis that 
strong Burst Mode TENS would produce significantly greater and longer 
lasting effects than those produced by High Rate TENS. 
The results from the study did not entirely support the hypothesis, 
but the significance of the findings suggested that continuing 
investigation into TENS action is warranted. 
(iv) 
This thesis contains no material which has been accepted for the award 
of any other degree in any University or College, and to the best of 
the candidate's knowledge and belief the thesis contains no material 
previously published or written by any other person except when due 
reference is made in the text of this work. 
'Karen Grimmer 
(v ) 
HYPOTHESIS  
The effects produced by the application of strong Burst Mode TENS 
will be greater and longer lasting than those produced by High Rate 
TENS. ** 
AIMS OF THE EXPERIMENT 
1. This experiment aims to determine whether strong Burst Mode TENS 
produces significantly greater immediate pain and stiffness 
relief than that produced by High Rate TENS. 
2. This experiment also aims to determine whether strong Burst Mode 
TENS produces significantly longer lasting pain and stiffness 
relief than that produced by High Rate TENS. 
3. This experiment aims to determine whether strong Burst Mode TENS 
produces significantly greater immediate objective changes than 
those produced by High Rate TENS. 
** The quantitative aspects of the hypothesis are covered in Section 
6.2. 
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1. 
CHAPTER 1. 
INTRODUCTION 
Arthritis. 
The generic term "arthritis" refers to all the conditions that 
cause "stiffness, soreness and pain in joints, encompassing acute and 
chronic conditions" (Apley 1977). Shane & Grant (1987) suggest, 
after reviewing the 1983 statistics of the U.S.A. Health Department, 
that 80% of 40 million people over 55 years of age have some form of 
joint degeneration. Hadler (1985), in an analysis of U.S.A. workdays 
lost from arthritic related conditions, predicts that chronic 
arthritis affects at least 40% of the adult working population with 
varying degrees of incapacity. Chronic osteoarthritis exists in three 
main forms; osteoarthritis, rheumatoid arthritis and gout (Corrigan & 
Maitland 1986). Osteoarthritis, the subject of this study, is 
generally described as a "wear and tear" disease (Grote 1987), and it 
is the middle aged and elderly who are affected most. Although 
epidemiological studies have not established it, there appears to be a 
higher ratio of women suffering from ostearthritis than men; various 
studies suggest that it may be unequal and unknown (Maquet 1978), 2:1 
(Hadler 1985) or 3:1 (Bland 1983). The preponderance of females in 
experimental studies by Taylor, Hallett & Flaherty (1981), 
Santiesteban (1983), Thorsteinsson, Stonnington, Stillwell & Elveback 
(1977,1978) and Mannheimer & Lampe (1984) seem to concur with a sex 
difference, although the reasons for the difference are not clear. 
Osteoarthritis can be divided into two categories: 
1. polyarticular degenerative arthritis, rarely occurring before 35 
years of age, 
2. monoarticular arthritis resulting from a particular joint surface 
incongruity occuring as a result of an injury or disease 
[Crenshaw (1971), Murray & Jacobson (1971)]. 
While the first category of osteoarthritis can affect joints 
indiscriminately, the weight bearing joints are mostly affected in the 
second category, as these are most likely to sustain injury. Of these, 
the hip and the knee are the most severely affected [Huskisson & 
Dudley-Hart (1978), Corrigan & Maitland (1986)]. It is considered that 
constant osteoarthritic pain would become chronic 6 months after 
diagnosis; after this time it could be expected that the joint pain 
would regularly affect the sufferer's lifestyle, mental attitude and 
physical expectations [ASP Subcommittee Report (1979), NH & MRC 
Report (1988)]. 
2. 
The knee joint has been chosen for this study because: 
1. its affliction by chronic osteoarthritis is relatively common 
(McCarty 1979), 
2. osteoarthritis of the knee is a separate and diagnosable condition 
using objective and functional measures (Cross & Crichton 1987), 
3. the anatomy and function of the knee is well documented 
[Hollinshead (1969), Gray's Anatomy (1972), Brunnstrom (1979)], 
4. the long term management of the pain and dysfunction in an 
osteoarthritic knee often is a problem for physiotherapist, doctor 
and patient (Smith, Lewith & Machin 1983), 
5. despite TENS applications for osteoarthritic knees being described 
in previous experiments, the parameters for successful, replicable 
and lasting pain relief have not been adequately validated [Smith 
et al (1983), Taylor et al (1981), Mannheimer et al (1984)], 
and 
6. the efficacy of pain relief with High Rate TENS and strong Burst 
Mode TENS applied to the same stimulation points at the knee has 
not been demonstrated. 
Current treatment for osteoarthritis of the knee ranges from 
surgery, administration of analgaesic and anti-inflammatory drugs, 
heat and cold therapy, physiotherapeutic electrotherapy measures, to 
exercises and/or rest. The efficacy of drug therapy has been 
questioned (Taylor & Ghosh 1981), as the peak and valley effects and 
the systemic conditioning created by long term drug administration 
have been recognised as undesirable in the long term [Duncan (1982), 
Shane & Grant (1987)]. The efficacy of most physiotherapeutic 
treatments (such as Ultrasound, Interferential, Shortwave therapy and 
exercise) is largely untested with respect to osteoarthritic 
conditions [Santiesteban (1983), Smith et al (1983), Care, Harefield 
& Chamberlain (1981)], although physiotherapists have always believed 
in the personal contact value of these treatment methods (Partridge 
1980). It has also been considered that diet may play a part in 
predisposing an individual to arthritic conditions, but this has not 
been rigorously scientifically tested [Pritikin (1985), Horne 
(1983), Phillips (1983)]. 
Transcutaneous Electrical Nerve Stimulation 
The application of Transcutaneous Electrical Nerve Stimulation and 
its effects on osteoarthritic pain is the best documented of all 
currently available, non-invasive, electrotherapeutic, pain relief 
measures. Placebo studies have been conducted since the development of 
TENS first created medical interest [Long (1974), Thorsteinsson et al 
1978)), and under controlled, blinded studies osteoarthritic 
conditions have been shown to respond well to Transcutaneous 
Electrical Nerve Stimulation [Mannheimer & Carlsson (1979) Dougherty 
(1979), Taylor et al (1981), Duncan (1982), Smith et al (1983)]. 
However, the optimal stimulation levels, electrode placements, lengths 
of stimulation time and pulse rates of appropriate TENS application 
are still disputed issues [Taylor et al (1981), Wolf, Gersh & Rao 
(1981), Medtronic (1982), Wolf & Gersh (1985), Mannheimer (1987)]. 
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Although electricity has been believed to be a pain relieving tool 
since early Roman days (Stillings 1974), the Pain Gate Theory of 1965 
created a resurgence of interest in its application for the relief of 
chronic pain [Melzack & Wall (1965), Shealy (1966)]. The Trans- 
cutaneous Electrical Nerve Stimulator was developed in the 1970's 
following awakened interest in a successful but forgotten model - the 
Electreat (Barcalow 1919). It was revised first in 1974 to become the 
Dorsal Column Stimulator, a screening device for potential dorsal horn 
implant patients [Shealy (1974), Long (1974)]. Such was the pre-
surgery success of this unit as a pain relieving tool, that the 
Transcutaneous Electrical Nerve Stimulator was developed as a separate 
treatment entity (Hymes 1984). 
Use of High Rate TENS (80 - 150 Hz), and more recently Low Rate 
TENS (2-3 Hz) has gained a place as an adjunct to medication and 
operative procedures to relieve chronic pain [Ersek (1977), Lampe & 
Mannheimer (1984)]. Strong Burst Mode TENS is an adaptation of Low 
Rate TENS, creating the same effects while using less intensity 
(Mannheimer 1987). The issue of which is the most effective TENS 
frequency in which circumstance is far from answered. Given that all 
treatment for chronic osteoarthritic pain has drawbacks, and that TENS 
therapy has been applied previously in clinical and experimental 
settings to osteoarthritic joints, this study aims to test whether 
strong Burst Mode TENS (pulse trains of 80 Hz internal frequency 
generated at 3Hz) produces significantly greater local pain and 
stiffness relief as well as significantly greater objective changes in 
osteoarthritic knees, when compared with High Rate TENS (80 Hz) and a 
placebo. 
Pain Relieving Actions of Transcutaneous Electrical Nerve Stimulation 
1. High Rate TENS  
The initially accepted action of High Rate Transcutaneous 
Electrical Nerve Stimulation was the excitation of the larger, 
myelinated nerve fibres which immediately inhibit segmental 
nociceptor reception at the Substancia Gelatinosa in the Dorsal 
Horn of the Spinal Column [Burton & Maurer (1974), Ersek (1977)]. 
Consequently, it has been suggested that the action of High Rate 
TENS may be most effective during application, but that pain relief 
is unlikely to last longer than the treatment [Burton et al (1974), 
Ersek 1977)]. The original Pain Gate Theory has since been 
extrapolated to incorporate theories of central inhibitory balance 
and pattern specificity [Shealy (1973), Watson (1981b), Wall 
(1978)]. Recent studies indicating longer periods of pain relief, 
after High Rate TENS application, have been published, but with few 
definite reasons for the results [Smith et al (1983), Dougherty 
(1979), Mannheimer et al (1984), Taylor et al (1981)]. The 
inclusion of such concepts as pattern generation (Melzack & Loeser 
1978), cognitive influence (Sternbach 1976) and higher cerebral 
input (Jacox 1977) into chronic pain reception mechanisms must be 
considered when discussing pain relief from High Rate TENS. 
4. 
Whether High Rate TENS triggers intrinsic opiate release after 
longer stimulation times has been discussed by Lundberg (1984), and 
Andersson & Holmgren (1978), but equivocal answers have been 
compounded by varying experimental techniques and results [Hughes, 
Lichstein, Whitlock & Harker (1984), O'Brian, Rutan, Sanborn & Omer 
(1984)]. Given the relaying potential of the ascending and descend-
ing tracts of the Dorsal Horn of the Spinal Column, it is possible 
that along with its already expounded action at segmental spinal 
levels and the higher brain, High Rate TENS may trigger some 
intrinsic opiate production, thus promoting a pain suppression loop 
involving segmental and central processes (Bishop 1980). 
2 Burst Mode and Low Rate TENS 
The concept of Low Rate TENS was developed from acupuncture 
stimulation by Eriksson & Sjglund (1976). Burst Mode TENS is a 
recent, more comfortable adaptation of Low Rate TENS (Mannheimer 
1987). Burst Mode TENS comprises trains of high frequency pulses 
generated at a low rate. At weak amplitudes, without muscle 
contraction, Burst N9de TENS can be used to produce a High Rate 
TENS effect, but at strong amplitudes, it has "the same net effect 
quantitatively and qualitatively as the single (Low Rate TENS) 
pulse at the same rate" (Mannheimer & Lampe 1984). It is this 
application which has been used in this study. Because of the 
analgaesic effect on patients with peripheral sensory neurological 
damage, low frequency TENS currents are thought to have little 
effect on the Pain Gate [Andersson & Holmgren (1975), Eriksson, 
Sjglund & Nielzen (1979)]. Low Rate and strong Burst Mode TENS 
produce a pulsed local afferent/efferent action which is too slow 
and generalised a stimulus to selectively conduct via fast acting 
myelinated fibres [Andersson (1978), Andersson, Hansson, Holmgren & 
Renberg (1976)]. Explanations of Low rate TENS action have been 
enhanced by the discovery of its effect on the intrinsic opiate 
release mechanisms in the spinal cord and brainstem [Synder & 
Matthyss (1975), Hughes, Smith, Kosterlitz, Fothergill, Morgan & 
Morris (1975), Eriksson et al (1979)]. Strong Burst Mode TENS has 
been shown to produce the same intrinsic opiate effect [Eriksson & Pt Sjglund (1976), Sjglund, Terenius & Eriksson (1977)]. 
Low Rate (and strong Burst Mode TENS) produce rhythmic muscle 
contractions. This action is considered essential for the 
stimulation of the intrinsic opiate mechanisms: the stronger the 
contraction, the more effective the intrinsic opiate stimulation 
(lelzack & Wall 1984). Low Rate TENS current must be applied at 
uncomfortable intensities for 30 minute or more (Holmgren 1975) to 
stimulate the release of intrinsic opiates (particularly B-
endorphin) from central brainstem areas. A negative feedback loop 
of pain suppression is thus possibly effected (Watson 1982). Low 
Rate TENS currents have a slow but increasingly powerful action 
during stimulation (Andersson 1979). It is known that intrinsic 
opiates affect peripheral synapses as well as synapses centrally, 
and investigation into Low Rate TENS action on peripheral synapses 
is under review (Mannheimer 1987). Until the development of Burst 
Mode TENS, difficulty in establishing a comfortable effective 
stimulation intensity restricted the use of Low rate TENS as a pain 
relieving modality (Melzack & Wall 1984). Strong Burst Mode TENS 
requires less current than Low Rate TENS to produce a strong muscle 
contraction, and thus may be better tolerated by the patient in 
pain (Eriksson, Sjglund & Nielzen 1979). 
5. 
Mannheimer (1987) considers that Low Rate TENS creates longer 
lasting pain relief (2 - 6 hours) than High Rate TENS because of 
the continuing action of the released intrinsic opiates. The 
literature promoting its use for orofacial pain (the best 
documented use, to date, of Low Rate TENS) suggests that it may 
create relief from chronic pain up to 18 hours after application 
[Andersson & Holmgren (1975), Chapman, Wilson & Gehrig (1976), 
Chapman, Chen & Bonica (1977)]. Andersson (1979) suggests that the 
muscular activity produced by Low Rate TENS increases the local 
blood supply, decreases local swelling and improves the surrounding 
muscle activity. Mannheimer (1987), and Lampe & Mannheimer (1984) 
indicate that strong Burst Mode TENS achieves the same effect. 
Given the need to avoid increasing the discomfort of subjects in 
the study, Burst Mode TENS of 3Hz pulse train with an internal 
frequency of 80 Hz was used to create the effects of a Low 
frequency TENS current. 
Application of TENS to Osteoarthritic Knees 
Consistently successful applications of TENS are slow to be 
established for specific conditions. Different, although apparently 
successful, applications of TENS to osteoarthritic knees are 
suggested by Mannheimer et al (1984), Thurin, Meehan & Gilbert 
(1980), Dougherty (1979), Andersson et al (1976), Melzack (1976), 
Smith et al (1983), Taylor et al (1981) amd Melzack et al (1984). 
Variations in parameters used in these trials highlight the dilemma 
of researching this field. The manufacture of increasingly 
sophisticated TENS apparatus is outstripping clinical knowledge of 
appropriate use of TENS options. Lundberg (1984), Mannheimer & 
Lampe (1984) and Wolf & Gersh (1985) urge continued, controlled 
clinical experimentation. Inadequate data, poor experimentation 
techniques, inadequate controls and confounding factors have 
plagued research in TENS use for pain control. Symptom relief by 
TENS for sufferers from osteoarthritis of the knee would improve 
daily lifestyle, and would reduce lost work time, use of 
medication, visits to medical personnel and surgery waiting lists. 
Use of Acupuncture Points for Electrode Placements  
Although the clinical use of acupuncture points for electrode 
placements has been suggested for both High Rate and Low Rate TENS, 
the reasons for the choice are different. The use of acupuncture 
points for High Rate TENS application has been mainly for 
convenience [Thurin et al (1980), Mannheimer et al (1984), Smith et 
al (1983)], because the action of High Rate TENS is considered to 
be neural blocking. As Low Rate TENS is an adaptation of acupunc-
ture, the placement of Low Rate TENS electrodes has always been 
over acupuncture points to enhance maximum endorphin stimulation 
[Andersson, Eriksson & Holmgren (1973), Andersson & Holmgren 
(1975), Melzack (1976), Melzack, Stillwell & Fox (1977)]. Use of 
acupuncture points is considered necessary for successful 
applications of Low Rate TENS (Mann, Bowsher, Mumford, Lipton & 
Miles 1973). However, the size of the TENS electrodes used in all 
these studies would make the stimulation of the pure acupuncture 
point questionable. Indeed, the same comment could be made about 
this study. The size of TENS electrodes presently available would 
make the isolated stimulation of acupuncture points impossible. 
Acupuncture points can be a guide only to anatomical placement. 
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Acupuncture points on the medial (Spleen 9), lateral (Gall 
Bladder 33), posterior (Urinary Bladder 40) and anterior (Spleen 
10) aspects of the knee have been used for this study. 
By stimulating over these points, most of the cutaneous nerves of 
the knee would be involved in the treatment, the entire knee joint 
would be irradiated (Essentials of Chinese Acupuncture 1980), and 
the four most painful areas of the osteoarthritic knee suggested by 
Smith et al (1983) would be covered. 
The Placebo 
The use of a nonfunctioning TENS to authenticate clinical 
experimentation has been discussed by Smith et al (1983), Hansson & 
Ekblom (1983), and Thorsteinsson et al (1978). Given the guidelines 
laid down in NH and MRC Statement on Human Experimentation and 
Supplementary Notes (1983), it is suggested that such placebo 
application constitutes a valid form of clinical experimentation. 
However, it has been suggested that a placebo application may 
itself induce the production of endomorphins [Levine, Gordon & 
Fields (1978), Skrabanek (1978), Chen (1980)], and it is possible 
that a placebo application of TENS may not give the baseline levels 
of response to TENS that are expected. Due to the inadequacy of 
most longterm medication and physiotherapy regimes for ongoing 
relief for osteoarthritis of the knee, the mere possibility of 
symptom reduction may create expectation of a result. 
Measurements 
1. Subjective  
The Absolute Visual Analogue Scale, chosen for this experiment, 
is considered an appropriate method by which clinical pain can be 
recorded (Zussman 1986). The inherent intervals are considered 
equal (Stewart 1977), the accuracy can be calculated to one decimal 
point (Scudds 1983) and the 10 cm continuum is considered 
statistically viable (Revill, Robinson, Rosen & Hogg 1976). The 
patient is not limited by lack of choice of descriptive words 
(Price, McGrath, Rafii & Buckingham 1983), nor by having to read 
and understand English (Stewart 1977), although the abstract 
quality of the scale "may frustrate some subjects" (Kremer, 
Atkinson & Ignelzi 1981). Zussman (1986) considers the scale "a 
reliable, convenient, inexpensive and readily analysable method of 
measuring subjective intensity". 
The measurement of stiffness by the Absolute Visual Analogue 
Scale has no precedent in the literature reviewed for this study. 
Stiffness is inherently a subjective measure, although change in 
stiffness is possibly related more to objective changes in the 
joint. Both Melzack (1975) and Stewart (1977) considered the 
Absolue Visual Analogue Scale a successful measuring device for any 
subjective assessment. Thus for ease of administering this 
experiment, a second, parallel, Absolute Visual Analogue Scale was 
used to measure immediate change in stiffness. 
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Verbal reports of length of pain and stiffness relief have been 
reported previously [(Smith et al (1983), Taylor et al (1981), 
Dougherty (1979), Mannheimer et al (1984)]. This author accepts the 
possibility of inaccurate reporting. However, it has been suggested 
by Altman (1986) that chronic sufferers of osteoarthritis of the 
knee are capable of being accurate when recording the diurnal 
variations of their pain, as they learn over time to accommodate 
their daily activities to their pain state. In this trial, subjects 
were asked to indicate when, over the 24 hour period following 
their TENS test, their post-test pain and stiffness returned to 
"normal". 
2. Objective  
The use of a goniometer to measure changes in knee joint range 
is discussed by Gifford (1914), Moore (1949), Twomey (1978) and 
Dougherty (1979). It is a commonly used tool in physiotherapy 
practice and provides an accurate measure of pivotal joint 
performance. Likewise the use of a tapemeasure to measure changes 
in joint circumference has been well established [Jacox (1977), 
Corrigan & Maitland (1986)]. Objective assessment is considered to 
be free of the bias that may affect subjective pain assessment 
[Berry & Huskisson (1972), Merskey (1974)], and it is felt that the 
inclusion of objective quantative measures may validate any 
improvement in knee joint function that this TENS application may 
produce. 
Conclusion  
TENS therapy is a possible adjunct to all forms of current 
treatment for osteoarthritis of the knee. It is claimed to be safe, 
painless, nonaddictive and easy to use [Ersek (1977), Hymes 
(1984)], and has application in both home and clinical settings 
(Mannheimer 1987). Its use has been dismissed as ineffective and 
painful (Griffin & McClure (1981) although it is possible that the 
method of application was inappropriate. Copious literature 
appeared in the late 1970's, exploring the use of TENS for a 
multitude of conditions. Poor experimentation technique, lack of 
specificity of conditions, and incomplete understanding of the 
biochemical actions of TENS caused many of these studies to be 
dismissed despite the invitation inherent in them to continue the 
research with more refined techniques. However, since the early 
1980's, there has been little more written on TENS therapy, despite 
the continuing lack of successful specific TENS parameters for 
particular conditions. The availability of increasingly 
sophisticated Transcutaneous Electrical Nerve Stimulators without 
the experimental literature to match, has highlighted the need for 
continuing research into the finer points of TENS application. It 
is hoped that this experiment will clarify the frequency variable 
of TENS for chronic osteoarthritic pain relief. 
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Summary of the Study. 
This double blind, randomised, controlled study compares the 
effects produced by High Rate and strong Burst Mode (Low Rate) 
TENS, when both are applied for the same time, at tolerable inten-
sities, at acupuncture points on painful osteoarthritic knees. 
Three groups of male and female subjects with present osteo- 
arthritic knee pain were tested with one application of either High 
Rate TENS, strong Burst Mode (Low Rate) TENS or a placebo. Measure-
ments of pain, stiffness, circumference and range of movement were 
taken before and after the test. This study, using a specified 
protocol for TENS administration, aimed to determine the most 
successful frequency of TENS for the relief of symptoms of 
osteoarthritis of the knee. Possible confounders such as the 
season, test time, and medication were controlled as far as was 
possible. The subject's sex and pain threshold were addressed by 
randomly assigning the subjects into the three test groups. 
Confounders which may have influenced the results were the 
subject's age, his expectations, his diet, and the length of time 
the subject had suffered from osteoarthritis. All measurements were 
taken by one person, who was independent of the study design and 
unaware of which TENS frequency was being administered to which 
subject. Because of its endorphin action, and the expected local 
tissue changes resulting from its effect on muscle contraction, it 
was hypothesised that strong Burst Mode TENS would produce 
significantly greater and longer lasting effects on chronic 
osteoarthritic knees than would High Rate TENS or the placebo. 
However, at 959 significance, it was found that strong Burst Mode 
TENS was not always the only effective TENS frequency. 
Key Findings 
1. Strong Burst Mode TENS, High Rate TENS, and the placebo all 
produced significant pain and stiffness relief, when comparing 
pre- and post-test Absolute Visual Analogue Scale readings. 
2. Strong Burst Mode TENS produced a significant length of post-
test pain relief only when compared with the placebo. 
3. Strong Burst Mode TENS did not produce significant immediate 
post-test stiffness relief when compared with High Rate TENS 
and placebo. 
4. Strong Burst Mode TENS and High Rate TENS both produced 
significant lengths of post-test stiffness relief when compared 
with the placebo. 
5. Strong Burst Mode TENS produced significant immediate post-test 
change in joint circumference only when compared with High Rate 
TENS. 
6. Strong Burst Mode TENS produced significant immediate post-test 
change in range of movement only when compared with the 
placebo. 
The lengths of pain and stiffness relief produced in this 
study, indicate that the actions of High Rate TENS and strong Burst 
Mode TENS could support further investigation. The choice of 
Transcutaneous Electrical Nerve Stimulator, the length of the TENS 
application, the subjects' age, the length of osteoarthritis 
diagnosis, the use of acupuncture points for electrode placement 
and the study design may have mediated pain and stiffness relief 
beyond that which was anticipated. 
CHAPTER 2 	 9. 
OSTEOARTHRITIS AND THE KNEE  
2.1 The Disease of Osteoarthritis 
In the literature reviewed for this work, this author found no 
generally accepted standard criteria for the diagnosis of 
osteoarthritis [Darby (1983), Hadler (1982), Bland (1983), Sokoloff 
(1969)]. Clinical criteria for the diagnosis of this disease are 
currently being developed by the American Rheumatism Foundation 
(Altman 1986). Clinical findings often differ from joint to joint, but 
common to all subjects with osteoarthritis are morning stiffness, 
changes in radiological joint composition, and the average age of 
sufferers being over forty (Altman 1986). Physiotherapists generally 
rely on a diagnosis of osteoarthritis to be made by the referring 
doctor. Lack of a clinical diagnosis necessitates nonspecific 
treatment. This is not cost or time effective. 
As the result of a study of physiotherapy attendance hours at 150 
Community Clinics in Michigan, U.S., in 1984, Stross, Banwell, Wolf & 
Becker (1986) suggest that radiologically confirmed osteoarthritis is 
one of the most common and debilitating diseases prevalent in modern 
society. It is characterised by "defects in articular cartilage and 
related change in subchondral bone, joint margins, synovium and para-
articular structures" (Altman 1986). Osteoarthritis has been 
documented since the days of Hippocrates (Darby 1983), although it 
was not until the 18th century that it was described separately from 
gout, and was recognised as a non-inflammatory and degenerative 
condition (Maquet 1976). In addition to the deterioration and 
abrasion of articular cartilage in affected joints, Sokoloff (1969) 
notes that osteoarthritis is recognisable "by formation of new bone at 
the articular surface". 
More women than men are affected by osteoarthritis (Corrigan & 
Maitland 1986) although the reasons for this are unclear. Studies by 
Hadler (1982), Taylor, Hallett and Flaherty (1981) and Bland (1983) 
indicate that women may be affected in the order of 2 or 3:1. As 
osteoarthritis usually affects people over forty, menopausal 
interference in joint function, suggested by Maquet (1976), may indeed 
be an issue. It is possible that changes in leg angles and heel strike 
caused by womens' fashionable footwear (high heeled shoes) and 
abnormal thigh action (obesity) may cause a higher incidence of 
osteoarthritis. Increased female pelvis/ femoral angle (Kendall, 
Kendall & Boynton 1952) may alter angular loading on weightbearing 
joints (particularly the knee) in women, thus predisposing it to 
degenerative changes. 
2.1.2 	The Causes of Osteoarthriti  
The causes of osteoarthritis are well documented. Cameron & Mehta 
(1984) suggest that osteoarthritis develops as a result of overloading 
the joint: by obesity, joint surface incongruity, or from normal 
loading on an abnormal joint consequent to trauma or disease. Darby 
(1983) and Altman (1986) mention the traditional separation of 
primary, or ideopathic, from secondary forms of osteoarthritis. Such 
secondary causes may be post traumatic, or as a result of congenital 
or developmental diseases, bone and joint disorders such as septic 
arthritis and osteoporosis, mechanical disorders like unequal limb 
length, or metabolic, endocrinal or neuropathic disturbances. 
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Analytical studies [(Maquet (1976), Radin (1973)1 suggest that 
osteoarthritis is not caused by any single factor and that research to 
establish "a unique causative mechanism" will not succeed. Murray & 
Jacobson (1971) report radiological studies of a large proportion of 
ideopathic osteoarthritics as having pre-existing abnormalities, while 
Solomon (1976) found that an identifiable cause of the disease could 
be isolated in 92% patients studied with degenerative joint disease. 
Perhaps the separation of ideopathic from secondary causes may not be 
as clear as was thought by earlier researchers. 
Some dispute exists however as to the exact trigger of the disease 
onset. Darby (1983) quotes variations in pathological presentation of 
the disease at autopsy, that expose the underlying lack of 
understanding of its mechanisms; "Why does fibrillation in some parts 
of the joint surface lead to osteoarthritis, while in others it is of 
limited progression? 	Is the synovial membrane an innocent 
bystander or does it play a leading role in initiating the disease 
process?" Altman (1986) notes that aspirated fluid from the synovium 
of an acutely inflammed osteoarthritic peripheral joint shows 
increased viscosity, with an increased white blood cell count, and 
raised protein and glucose levels. He quotes operative findings in 
that the cartilage of an affected joint also differs from that of a 
healthy joint, being frayed, ulcerated, yellowed and of irregular 
depth. 
The illustration below looks at factors that may contribute to the 
establishment of osteoarthritis in a joint: "Clinical osteoarthritis 
appears to be the end result of a complex series of interconnected 
vicious circles..., one or more entry points into the series seems 
possible" (Darby (1983). 
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2.2 Osteoarthritis of the Knee 
The knee is one of the most common sites in the body for the 
establishment of osteoarthritis, as it is directly affected by injury, 
abnormal weight bearing patterns, obesity and joint incongruity 
(Adams 1971). Osteoarthritis can occur unilaterally in the medial 
compartment, the lateral compartment and/or the patellofemoral 
compartment. It can also occur in a generalised form throughout the 
joint. The medial compartment is the most common site of the disease, 
as it is constantly under load by postural alignment and body sway 
(Cameron & Mehta 1984). 
Osteoarthritis of the knee may be caused by several precipitating 
factors. It is accepted that the presence of the meniscus plays an 
important role in maintaining joint surface congruity (Gray's Anatomy 
1972) and changes in its state, or its absence, may alter the forces 
experienced across the joint during normal weight bearing, thus 
predisposing the joint to osteoarthritic changes (Maquet 1976). 
Although obesity is often quoted as a cause of osteoarthritis of the 
knee, both Sasaki & Yasuda (1987) and Altman (1986) suggest that it 
may be the altered heel strike and subsequent varus knee and heel 
posture that occurs as a result of obese thighs that may precipitate 
constant wearing of the knee joint surface. Joint incongruity or 
altered leg length from previous bony trauma will also alter weight 
bearing posture and thus encourage abnormal joint wear. 
On researching this paper, the most recent, comprehensive list of 
clinical signs of osteoarthritis of the knee appears in Altman (1986); 
" 1. Pain; on weight bearing, aching, present on most days. 
2. Age; usually over 40 years. 
3. Morning stiffness for >30 minutes. 
4. Crepitus on active movement. 
5. Bony joint margins; tender, palpably enlarged. 
6. Palpable effusion; relatively cool or none. 
7. Synovial fluid; clear, viscous, contains < 2,000 WBC/ml. 
8. Changes in bony conformation as seen on X-ray." 
2.3 Symptoms of Osteoarthritis relating to the Knee. 
The symptoms of osteoarthritis of the knee combine subjective 
reports of pain and lack of function, objective assessment of 
changes in joint shape and strength, and radiological definition 
of joint destruction [Calabro (1986), Altman (1986)1 
2.3.1 Pain 
Apley (1977) writes: "Pain is the major symptom of O.A. In 
early stages it is present on waking, and then wears off with 
movement. With further use, the joint begins to ache. As the 
disease progresses, pain increases in severity and consistency, 
sometimes disturbing sleep." An observational study by Helal 
(1965) divides the pain of primary osteoarthritis into muscular, 
venous and capsular origins. With respect to the knee: 
1. 	Muscular pain occurs in the quadriceps, hamstring and 
gastrocnemius muscles. It is cramplike on activity and improves 
with rest. It occurs as a result of muscle fatigue, and 
metabolic waste accumulation, in muscles which have been 
allowed to weaken through disuse. 
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2. Venous pain is "a dull aching or throbbing ....felt around 
the knee, usually worse towards the end of the day and 
persisting for a while after retiring to bed" (Helal 1965). It 
may be as a result of deformation of bone sinuses, thus pooling 
blood in the joint endings. This pain is thought to involve C 
fibre activity (Mackenny & Harris 1983). 
3. Capsular pain is sharp pain felt on joint movement. It is 
the most common feature of osteoarthritis of the knee (Apley 
1977), and is a result of capsular contractures being stretched 
during knee movement. Cyriax (1977) notes the pain felt at the 
end of range of movement may be capsular stretch rather than 
muscle spasm as was thought previously, and thus because of its 
acute, protective nature may involve A delta fibres (Helal 
1965) 
It has been suggested that the capsular and ligamentous 
structures of joints are also richly supplied with C fibres 
(Mannheimer, Lund & Carlsson 1978), which may account for the 
diffuse ache which persists deep in the joint despite 
conservative medical attention (Corrigan 1986). 
4. Cyriax (1977) describes another pain type, that of 
"grinding bone on bone when articular cartilage is worn away." 
This is considered mostly A delta pain transmission as 
cartilage has no nerve supply, while periosteum is well 
supplied with faster acting afferent nerves (Apley 1977). 
Melzack and Taenzer (1977) spoke of pattern generating 
mechanisms in the dorsal horn of the spinal column. It is 
possible that chronic osteoarthritis results in abnormal pain 
patterns being generated, thus establishing avoidance behavior 
(Merskey & Spear (1967). Osteoarthritis sufferers are aware of 
their limitations and may impose restrictions on their daily 
activities in the hope of minimising their pain (Altman 1986). 
The diurnal pain variation, functional changes with respect to 
the weather, and the effect of some foods, activities, and 
even wearing apparel have been noted [Jacox (1977), Berry & 
Huskisson (1972), Clark & Spear (1964)]. 
	
2.3.2 	Joint shape and strength (FIG 2B) 
Swelling and deformity are evident in most chronic osteoarthritic 
joints. The knee is more prone to OA involvement (Mackenny & Harris 
1983) because of the complicated mechanics involved in knee movement, 
and because of its propensity for attracting trauma. Maquet (1976) 
noted that forces "up to three times the body weight cross the knee 
joint during normal walking", which lead Mackenny et al (1983) to 
suggest "that minor derangements in function may produce excessive 
localised abnormal loading leading to cartilage failure". 
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FIG. 2B Differences between normal and osteoarthritic joint 
Orthopaedic factors such as quadriceps weakness and genu valgum/ 
varus, and forefoot/rearfoot instability, may result in 
"unicompartmental degeneration of cartilage" given normal useage over 
time (Crenshaw 1971). Such quadriceps weakness will be apparent as 
wasting, and the underlying joint may appear more noticeably 
disfigured (Apley 1977). Soft tissue changes such as inflammed Wor 
thickened synovium may be objectively noticeable, as will swelling 
infiltrating the infra- and suprapatella bursae (Darby 1983). 
Joint instability may be detected, as weakness resulting from 
frayed cruciate, medial and/or lateral collateral ligaments may not be 
overridden by the disease-mediated fibrosis of the ligamentous and 
capsular interconnections. Destruction of the articular cartilage and 
the menisci may also predispose to instability, especially if the 
quadriceps and hamstring static balance is not maintained [Corrigan 
and Maitland (1986), McConnell 1986)]. 
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2.3.3 	Radiological evidence 
The most commonly used method of diagnosing osteoarthritis of the 
knee is by X-ray. Features recognised when diagnosing osteoarthritis 
include; 
I. Joint remodelling. (FIG. 2C) 
This is the most striking feature of osteoarthritis of a joint. 
Unfortunately confirmed by autopsy findings, it indicates that the 
disease process is well established (Mackenny et al 1983). 
Flattening of the weight bearing area of the bones involved occurs 
because of the destruction of cartilage, and the change is made more 
apparent by the formation of osteophytes at the margins of the 
joint, thus expanding the periphery of the joint profile. "Regress-
ive remodelling" occurs centrally in the joint by way of osteo-
blastic activity, following surface destruction. "Progressive 
remodelling" occurs at the joint edges when articular cartilage 
reverts to its original childhood function of a growth plate (Darby 
1983). 
Scale: I in 4 
FIG. 2C 	X-ray of osteoarthritic knee 
2. Pathological changes in cartilage. 
Anatomical studies lead Crenshaw (1971) and Cyriax (1977) to 
agree that degeneration of articular cartilage is "the hallmark, if 
not the actual cause, of osteoarthritis". The initial change 
appears as fibrillation of the superficial layers of the cartilage, 
involving disruption of collagen fibres in the mattrix. Clefts occur 
in progressive degeneration of cartilage "extending vertically 
and/or tangentially" (Darby 1983) into the deeper cartilage layers, 
leading to eventual fragmentation of the superficial cartilage. 
Abrasive action from the opposing joint surface increases the loss 
of cartilage once the destructive mechanism is established. Increase 
in the activity of articular chondrocytes can be seen adjacent to 
the clefts, as a result of cellular proliferation - a protective 
reaction to the inherent destruction of cells. This reaction can be 
observed in pathology tests, and when well established, in X-rays 
(Cyriax 1977). 
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3. Changes in Subchondral Bone. 
As destructive changes occur in superficial cartilage, the 
underlying bone is exposed to the erosive activity of the opposing 
joint surface. This leads to loss of end-bone substance, and a 
polishing effect known as "eburnation" occurs (Apley 1977). 
Friction and direct trauma lead to the loss of osteocytes, which may 
present as local avascular necrosis of bone, or fractures of the 
subchondral bone in advanced cases. However, the surviving bone 
cells show an increase in activity; weightbearing bony areas show 
higher than normal levels of osteoblast and osteoclast activity, 
resulting in radiological evidence of sclerosis (Crenshaw 1971). 
4. Subchondral pseudo- cysts 
This feature is found in other pathologies besides 
osteoarthritis, and the description is a radiological rather than a 
histological one. Cysts are areas of bone replaced by fibrous 
tissue, sometimes containing viscous fluid, and the whole area is 
usually lined with sclerotic bone. It is thought (Darby 1983) that 
the cysts result from high intra - articular pressure, which forces 
synovial fluid into the cavities in articular cartilage and 
subchondral bone created by earlier stages in the disease. However, 
because pseudo - cysts are also demonstrated in other pathologies 
whose etiologies differ from osteoarthritis, the real reason for 
their formation is not known. 
2.4 Treatment of osteoarthritis of the knee 
The objectives of all treatment of osteoarthritis of the knee are 
to reduce pain and to improve function ((Altman (1986), Calabro 
(1986), Stross, Banwell, Wolf & Becker (1986)]. 
Common methods can include one or more of the following: 
1. surgery to reduce the loading on the knee or to replace the joint 
2. physiotherapy procedures to relieve local pain and to increase 
strength in the surrounding protective muscle groups, 
3. altering the angle of heel strike by shoe inserts, 
4. pharmaceutical agents and 
5. joint protection by external aids. 
2.4.1 Surgery is employed when the destruction of the joint defies 
conservative treatment. It commonly takes two forms; tibial osteotomy 
to relieve the load on the joint, or total knee relacement (Corrigan 
& Maitland 1986). Joint debridement and unicompartmental arthroplasy 
are mentioned for younger sufferers (Cameron & Mehta 1986). The 
improving nature of artificial joint materials means that the age of 
total knee replacement patients is gradually lowering, although it 
would appear that surgical intervention is still a last resort 
(Sasaki & Yasuda 1987). 
2.4.2 Physiotherapeutic procedures used in the conservative management 
of osteoarthritic knee pain vary. A critical issue is that so many of 
the electrotherapy measures used are untested with respect to their 
actions on osteoarthritis (Santiesteban 1983). Heat, ice and massage 
are often used in the management of acute joint pain and muscle spasm 
(Altman 1986), while ultrasound, Diathermy, Interferential, Laser 
therapy, and Transcutaneous Electrical Nerve Stimulation are suggested 
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for increasing the blood supply, decreasing sensory nerve irritability 
and improving muscle function [Taylor et al (1981), Smith, Lewith & 
Machin (1983), Scott 1969)]. Regular exercise to improve muscle 
performance, and strength and balance around the knee are vitally 
important to protect joint movement and compensate for absent or weak 
ligaments [Cameron & Mehta (1986), Care, Harefield & Chamberlain 
(1981)]. Assessment of posture, advice on the use of shoe raises or 
wedges and the important task of educating patients in lifestyle and 
use of aids to relieve joint load is also a physiotherapist's  charter 
(Altman 1986). Partridge (1980) notes that empathy and concern in the 
overall care of chronic arthritics is not to be overlooked in 
treatment value. 
2.4.3 Pharmacological agents are usually involved in successful 
conservative management of osteoarthritis of the knee. It was 
important that medication be recognised as a possible confounding 
factor in this trial, and thus be controlled in the study design. 
Four classes of drugs are commonly used. 
1. Anti-inflammatory agents including aspirin and some non-narcotic, 
nonsteroidal drugs are given to reduce inflammation at the joint 
site. These drugs are antipyretic, and are specific in blocking 
the actions of irritating chemicals on the cell membrane. 
Unfortunately, adverse multisystem reactions reported by 'some 
patients for all of the current NSAIDs on the market suggests 
that prescription of long term antiinflammatory drugs alone may 
not be indicated [Calabro (1986), Shane & Grant (1986)]. 
2. Muscle relaxants or antispasmodic drugs have a place in inducing 
relaxation in the soft tissues surrounding the affected joint. 
3. Analgaesics for short term pain relief are an important measure 
in combatting acute exacerbations of osteoarthritis, but 
undesirable peak and valley effects of regular medication, and 
the systemic conditioning problems associated with long term drug 
administration are noted by Taylor & Ghosh (1981) and Duncan 
(1982). 
4. Depocorticosteroids are valuable for an inflammed joint, but are 
not desirable for longterm management (Altman 1986). 
2.4.4 Aids useful in the management of osteoarthritis of the knee 
range from walking sticks, canes and knee braces to pickup sticks, 
altered seat heights, and ramps to reduce joint load. If the patient 
is overweight, a diet may be indicated. A change in diet to reduce 
fats may also be suggested, as it is indicated by Grote (1987), Bland 
(1983), Pritikin (1985) and Horne (1983) that an improvement in 
osteoarthritic joint function can occur if dietary intake is higher in 
fibre and lower in fats. 
2.5 Conclusion 
Osteoarthritis is a debilitating disease which affects not only 
the individual, his family and friends, but also the economy of his 
country. It has many causes with a documented sequence of biochemical 
events leading to the destruction of the joint surface. There is as 
yet no successful cure, and even long term pain and dysfunction relief 
is not guaranteed by present day therapies. It is a condition which 
invites investigation by TENS therapy, because the possibilities of a 
safe, home based, electrical form of pain mediation that may help to 
reduce medication and increase joint function are persuasive. 
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CHAPTER 3 
MECHANISMS OF PAIN MODULATION RELATED TO TRANSCUTANEOUS 
ELECTRICAL NERVE STIMULATION 
Transcutaneous Electrical Nerve Stimulation is known to temporarily 
elevate the human pain threshold, thus improving the sUfferer's ability 
to deal with his pain (Wolf & Gersh 1985). How TENS affects the pain 
threshold remains a subject for further experimentation. 
3.1 The Function of Pain  
Pain acts as a warning and as a teacher (Best & Taylor 1973). 
Tissue damage or a threat of impending damage activates local pain 
receptors, to notify the body to take action to avoid further injury 
(Watson 1981a). Without adequate pain reception, injuries can occur 
which lead to a degradation in lifestyle. Conditions which are 
characterised by reduced pain appreciation, such as hemiplegia, 
paraplegia and peripheral neuropathies, can be complicated by skin 
ulceration, limb fractures, joint dislocations, burns, pressure sores, 
infections and arthritis (Hopps 1964). 
3.2 Action Potentials  
Neurological studies on animals have shown that impulses travelling 
along a nerve fibre do so by electrical activity (Zimmerman 1976). 
Immediately a receptor is stimulated, an action potential is created by 
a wave-like flow of sodium and potassium ions in and out of the nerve 
cell. When a synapse is reached, the current is propagated by chemical 
transmitters across the synaptic space (Best & Taylor 1973), ensuring 
that the electrical impulse continues into the next structure. The 
frequency of generated action potentials is dependant on the intensity 
of the electrical stimulation. As the maximum frequency of a fibre is 
reached, additional afferent fibres are recruited to carry the impulse 
(Watson 1981a). Knowledge of the behaviour of fibres being stimulated 
by TENS should be relevant to predicting both the result, and the 
intensity needed to maintain a minimum effect (Wolf 1984). 
3.3 Pain Receptors  
The most common pain receptor is the free nerve ending, found in 
skin, ligaments, joints, muscles and periosteum (Kenshalo 1968). 
Specific receptors can have specialised functions such as taste, 
temperature, vision and hearing reception, but all receptors can 
appreciate pain if the intensity of the impulse is sufficiently great 
(Wolf 1984). The mechanism by which pain receptors are activated is 
thought to be the release of chemical substances which cause pain 
directly, or reduce local pain thresholds (Charl 1979). Naturally 
occurring substances such as 5 - Hydroxytryptamine, Substance P, 
bradykinin and some of the prostaglandins (natural occurring lipids) 
are thought to aggravate pain receptors, when released as a result of 
local injury. The subsequent current flow initiates a nerve impulse 
[Charl & Kirk (1975), Watson (1981b)]. 
Neurographic research has enabled peripheral pain impulses to be 
traced consistantly along the A-delta and C fibres (Torebjork & 
Hallin 1974). Zimmerman (1976), TorebjOrk & Hallin (1974) and Willis 
& Grossman (1973) currently accept a classification of human afferent 
nerve fibres. This is reproduced from Willis et al (1973). 
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Table 3.1 	Presumed actions of afferent nerve fibres 
r, 
Type Group Subgroup Diameter 
(u) 
Conduction 
Velocity(m/sec) 
Presumed Function 
A I la 12-20 72 - 120 Signal muscle velocity 
and length change. 
A I lb Signal muscle shorten-
ing of rapid speed. 
A II Muscle 6-12 36 - 72 Signal muscle length 
changes. 
A II Skin Convey information 
from touch receptors. 	- 
:A delta III Muscle 1-6: 6 - 36 Convey information 
, . I 
from pain - pressure 
receptors. 
:A delta 
. 
. 
III Skin Convey information 
from pain, temperature 
or touch receptors. 
:C 
. 
IV Muscle 1 0.5-2 Convey information 
from pain receptors 
:C 
. 
. 
IV Skin Convey information 
from pain, temperature 
or touch receptors. 
3.4 Ascending Spinal Pathways  
Peripheral nerve fibres enter the spinal cord via the dorsal 
roots (Shealy, Mortimer & Reswich 1967). Actions of the ascending 
and descending tracts to the brain, have been established after 
electromyographical and surgical intervention in both humans and 
animals (Bishop 1980). The major spinal ascending pain pathway is 
thought to be the lateral spinothalamic tract (LSTT) (Watson 1981b). 
It carries thermal, pain, tactile, sexual and proprioceptive 
information (Noordenbos & Wall 1976), having both specific pain and 
sensory transmittor cells (Watson 1981b). Other ascending pathways, 
(such as the Dorsal funiculus) are known to carry pain information, 
but the LSTT is currently considered to be the main noxious pathway. 
3.5 Connections at the Brain  
3.5.1 LSTT fibres project initially to the ventroposterolateral 
nucleus of the thalamus, from where fibres carrying pain information 
project to the primary somatosensory cortex, an area concerned with 
the discriminative aspects of sensation such as localisation and 
identification of specific sensations and intensities. The medullary 
Reticular Formation, the Periaqueductal Grey, the Nucleus Rophe 
Magnus, and Nucleus Cuneiformis receive LSTT fibres at the midbrain 
level (Watson 1981b). These areas have connections to the medial 
thalamus, secondary somatosensory cortex and the hypothalamus, thus 
involving motivational, affective and autonomic responses to pain. 
The Periaqueductal Grey and Nucleus Rophe Magnus may be involved in a 
negative feedback loop (Basbaum 1980) (FIG. 3A) to suppress pain 
information segmentally. 
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DLF - Dorsolateral Funiculus 
DRG - Dorsal Root Ganglion 
NRM - Nucleus Raphe Magnus 
RMC - Nucleus Reticularis Magnocellularis 
RGC - Nucleus Reticularis Gigantocellularis 
PAG - Periaqueductal Grey 
Representative diagram only 
FIG. 3A Negative Feedback Loop  
3.5.2 The LSTT has connections to the Ascending Reticular Activating 
System which changes levels of consciousness and awareness. Cultural 
conditioning, posture, education, sympathetic nervous reactions and 
wellbeing may mediate pain reception via these pathways (Sternbach 
(1974), Watson (1981a)]. Cognitive influence in pain appreciation 
has yet to be fully explored. It is known that anxiety, stress, past 
experience, mental health, fatigue, and cultural attitudes alter the 
body's ability to perceive pain, but the method by which these inputs 
alter pain appreciation is still largely hypothesis. Descending 
cortical pathways may be involved in the feedback system where 
afferent input stimulates cortical output, which suppresses or 
stimulates afferent reception segmentally (Sternbach (1975). 
Expectations associated with TENS for chronic pain relief, especially 
in an osteoarthritic condition where other forms of pain relief may 
have failed, cannot be discounted as a reason for success. 
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3.6 Theories of Neural Transmission of Pain 
The efficacy of Transcutaneous Electrical Nerve Stimulation in 
pain relief may be explained by the following theories. However, 
Lundberg (1984) suggested, after reviewing the current TENS 
literature, that the effects of TENS may not be explained adequately 
by current knowledge of neurophysiology, anatomy or psychology. His 
views concur with those of Wolf & Gersh (1985): knowledge of TENS 
action may never be fully understood because of the complexities and 
individual eccentricities of the human body. 
3.6.1 The "Pattern Theory" (Nafe 1929) hypothesises that sensation 
is not relayed by specific receptors, but rather by the pattern, 
frequency and intensity of impulses arriving in the brain. The 
pattern theory provides a possible basis for pain relief continuing 
after ceasing TENS; i.e. TENS may disrupt the "normal" chronic pain 
pattern to allow the establishment of a more acceptable pattern, by 
some other therapeutic modality such as exercise, massage or 
mobilisation. A return to "normal" may occur up to one hour after 
pattern disruption, unless a stronger, more dominant and permanent 
pattern is established in that time (Melzack & Loeser 1978). 
3.6.2 The Pain Gate Theory (Melzack & Wall 1965) initially 
described "the constant and dynamic interaction between large 
diameter (A alpha, beta & gamma fibre) inputs and smaller diameter 
noxious (A delta and C fibre) inputs at the segmental level of the 
spinal cord". The Pain Gate theory has been confirmed by the 
identification of transmitter cells and interneurons in the Dorsal 
Horn, whose axons transmit pain sensations to the brain (Cervero & 
Iggo 1980). This theory possibly explains the immediate pain 
blocking effect of High Rate TENS. 
3.6.3 The Central Biasing Theory, which evolved as a result of the 
Pain Gate mechanism, includes the possibility of influence in pain 
mediation by higher brain centres as well as spinal segmental 
inhibition [Melzack & Taenzer (1977), Melzack & Loeser (1978), Wall 
(1978)] (FIG. 3B). This mechanism may explain both the immediate and 
continuing action of High Rate TENS on chronic pain [(Ersek 1977), 
Melzack & Wall (1983)]. 
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FIG. 3B Central Biasing Mechanisms (Melzack & Loeser (1978) 
incorporating Melzack & Wall Pain Gate Theory (1965) 
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3.7 Endogenous Biochemical Theories of Pain Modulation 
3.7.1 Research over the last fifteen years has explored the 
biochemical and neuropharmacological aspects of pain mediation. 
Acupuncture analgaesia, induced both by needle and Low Rate TENS, 
has been found to increase individual levels of endogenous opiates, 
[Levine, Gormley & Fields (1976), Hughes, Smith, Kosterlitz, 
Fothergill, Morgan & Morris (1975)1, but the mechanisms and 
components of such opiate release remain areas of debate. 
3.7.2 The discovery of endogenous opiates and their receptors in the 
Periacqueductal Grey and the Nucleus Rophe Magnus raised questions 
about the chemical control of the Spinal Cord Dorsal Horn afferent 
pathways by higher centres (Bishop 1980). Basbaum & Fields (1978) 
postulated that a negative feedback loop may involve neuromodulation 
by pharmacological substances as well as neural mechanisms (FIG. 
3A). Electrical stimulation of the human Periaqueductal Grey and 
Nucleus Rophe Magnus has been shown to inhibit the transmitting 
actions of Dorsal Horn neurons (Giesler, Gerhart, Yezierski, Wilcox 
and Willis 1981). The clinical effects of such inhibition include 
increases in pain threshold over prolonged periods (Nolan 1987). 
3.7.3 Opiate receptors have been found at all levels of the dorsal 
horn of the spinal cord. Binding endogenous opiates, (released via a 
descending modulatory system) (Basbaum 1980) to local opiate receptor 
sites at any spinal segmental level could explain a regional blocking 
mechanism that may complement segmental neural inhibition of pain 
impulses (Bishop 1980). 
3.7.4 Peripheral synapses are also implicated in opiate blocking 
activity. Cervero & Iggo (1978) consider that intrinsic opiate 
receptors exist at most peripheral synapses, and can be activated or 
suppressed by chemicals that transmit pain. Substance P and serotonin 
are thought to be the main peripheral synaptic neuro-transmitters. 
When liberated as a result of local trauma, Substance P excites the 
neurons that are sensitive to pain, thus propagating pain impulses. 
In low doses, synaptic Substance P appears to inhibit pain 
appreciation by aiding release of local endorphins (Henry 1980). 
Serotonin is a naturally occuring amino acid involved in 
temperature, pain, sleep, mood and appetite regulation (Mayer, Price 
& Rafii 1977). When released by local trauma, serotonin aggravates 
peripheral synaptic chemoreceptors. At brain and spinal cord 
synapses, however, serotonin supresses cells which receive pain 
input, thus enhancing release of endogenous opiates (Handwerker 
1980). Adequate levels of dietarytryptophan are required to maintain 
serotonin manufacture in humans. Vitamin B3 (gained from eggs, meat, 
poultry and dairy products) must be eaten in sufficient quantities to 
maintain tryptophan levels. It is suggested that chronic pain may 
cause the depletion of serotonin stores by constant stress and/or 
inadequate diet (Shanks, Clement-Jones & Linsell 1981). Reduction in 
serotonin production may result in inadequate levels of endorphin 
production, thus altering pain thresholds (Mannheimer et al 1984). 
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3.8 Endogenous Opiates 
Concentrations of intrinsic opiates in normal blood fluctuate in a 
circadian manner (Terenius 1979). Lowest baseline levels of plasma 
intrinsic opiates can be expected in the afternoon. Levels also vary 
according to the season; being lowest in the winter (Hughes et al 
1984). Chronic pain subjects have been found to havelower CSF and 
plasma concentrations of endogenous opiates [Sjolund, Terenius & 
Eriksson (1977), Terenius & Wahlstrom (1975)]. Terenius et al (1975) 
suggests that this may be as a result of hypoactivity of the systems 
releasing endorphins, while Sj6lund et al (1977) postulate that 
chronic pain patients may have a higher consumption of released 
endorphins. 
3.8.1 Endorphins 
Endorphins have been defined (Matsukura 1978) as long alpha- and 
beta- peptide cbains existing in the CNS and peripheral synapses. 
Stimulation of the Periaqueductal Grey and Nucleus Rophe Magnus 
releases B-endorphin, which has behavioral consequences similar to 
those observed in morphine administration [Giesler & Liebeskind 
(1976), Liebeskind & Paul (1977)]. 
B-endorphin has been described as the longest acting and most 
potent of the endogenous opiates, (Tseng, Loh & Li 1976), being 30 
times more potent on a molar basis than morphine. It is a 31 amino 
acid chain, an independant part of the pituitary hormone B-
lipotropin. Kosterlitz (1979), and Ignelzi & Atkinson (1980) estimate 
its half life as at least 2 - 3 hours, as it is resistant to enzyme 
degradation. It is released by the pituitry gland in response to 
repeated stressful stimuli, and appears in the Cerebrospinal fluid 
within 30 minutes of such a stimulus commencing [Sj6lund & Eriksson 
(1979), Akil et al (1978), Terenius (1979)]. Traces of B-endorphin 
have been found in the blood stream 24 hours after ceasing 
stimulation (Shanks, Clement-Jones & Linsell (1981). B-endorphin 
receptors at synapses (both peripheral and central) have been shown 
to be blocked by the administration of naloxone hypochloride, thus 
reversing endorphin mediated analgaesia [Sjglund & Eriksson (1979), 
Terenius (1979), O'Brien et al (1984), Hughes et al (1984)]. 
3.8.2 Enkephalins. 
The enkephalin group of methionine- and leucine-enkephalin is 
composed of short chain (5 amino acid) peptides, found in the 
Periaqueductal Grey, Limbic System, Basal Ganglia, inter-neurones, 
Hypothalamus and Spinal Cord. Enkephalins have rapid enzymatic 
degradation, having half lives of less than one minute (Ignelzi & 
Atkinson 1980). Hughes et al (1975) suggested that enkephalins were 
weak morphine-like agonists, with leucine-enkephalin being half as 
strong as methionine-enkephalin. It does not appear that their 
receptors are blocked by naloxone (Clement-Jones, McLoughlin, 
Tombin, Besser, Rees & Wen 1980). Given descriptions of experimental 
data to hand, naloxone, administered within 15 minutes of TENS 
activity [SjOlund & Eriksson (1979), O'Brian et al (1984), Hughes et 
al (1984)] may not inhibit enkephalin activity simply because the 
enkephalins already have been broken down. 
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3.8.3 Other intrinsic opiates 
Peptides with intrinsic opiate activity are still being 
discovered (Mannheimer et al 1984). Already, several with actions 
stronger than B-endorphin have been isolated; neurotensin, bombesin, 
dynorphin and angiotensin [Miller & Deyo (1980), Basbaum (1980)]. 
Increased levels of the hormones ACTH and B-lipotropin also have been 
found in CSF following stimulation of endorphin activity by repeated 
stressful stimuli. 
3.8.4 Endogenous Opiates and TENS 
The discovery of increased B - endorphin levels in the CSF, 
brainstem and blood stream after Low Rate TENS application 
has been well documented [(Andersson, Eriksson & Holmgren (1973), 
Andersson & Holmgren (1975), Mannheimer et al (1984)], although 
dispute exists in the literature as to whether intrinsic opiates are 
stimulated by High Rate TENS application [Andersson & Holmgren 
(1978), Hughes et al (1984), O'Brian et al (1984)]. SjOlund & 
Eriksson (1979) and Clement-Jones (1983) found, after studies on 
experimental pain, that naloxone reverses the effects of Low rate 
TENS, but not High Rate TENS. Hughes et al (1984) suggest that the 
High Rate TENS effect (thought to be mainly a spinal nerve blocking 
action), may also be mediated by enkephalin production, but its half 
life may render it inactive before naloxone can block it. 
Understanding of this issue is far from clear. 
3.9 The Effects of Naloxone Hypochloride  
Naloxone hypochloride is a specific narcotic antagonist which has 
no morphine-like actions. It acts within two minutes of intravenous 
injection. Unfortunately, experimental differences with naloxone 
reactions on humans have been found to exist (Buchsbaum, Davis & 
Bunney 1977); humans with low pain thresholds obtain increases in 
pain perception from naloxone administration, while pain sensitivity 
decreases in patients with high pain thresholds. Naloxone may not 
block all intrinsic opiate receptors. Chronic pain sufferers differ 
from experimental pain subjects in that they have lower "normal" pain 
thresholds. The concentration amd composition of endogenous opiates 
stimulated by chronic pain may also differ from those found in single 
experimental pain experiments (Sj81und, Terenius & Eriksson 1977). 
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3.10 Conclusion 
An impasse is evident in the argument of chemical versus neural 
pain pathways in TENS mediated pain relief (Bishop 1980) (FIG. 3C) 
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FIG 3C Chemical v. Neural Pathways in Pain Mediation 
Lampe & Mannheimer (1984) describe the current pain transmission 
mechanism dilemma; "A proper mixture of chemical, electrical and 
neural events must take place at the synapse for inhibition or 
facilitation of nociceptive impulses to occur. The physiologic action 
of TENS can no longer be explained solely by the gate control theory, 
or by neuropeptide liberation. Clarification of the mechanisms by 
which the applications of High and Low rate Transcutaneous Electrical 
Nerve Stimulation to painful conditions may relieve pain is imperative 
to enhance the understanding of these powerful modalities". The 
concept of post TENS stimulation modulation of pain, possibly via 
descending cortico-spinal systems coupled with a physiological and /or 
narcotic .spinal blocking mechanism, presents TENS experimenters with 
continuing future areas of research. 
CHAPTER 4 	 26. 
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR DESIGN; 
VARIABLES OF APPLICATION. 
4.1 Transcutaneous Electrical Nerve Stimulator Design  
4.1.1 	Transcutaneous Electrical Nerve Stimulator current is low 
voltage, direct current. Batteries are used to power the circuit, 
ensuring portability, and freedom from mains shock (Wall 1985). TENS 
current is composed of a biphasic balanced waveform with a nett zero 
current component (Medtronic Selectra Manual 1984). The Medtronic 
Selectra TENS alternately generates current from both electrodes. 
Three waveforms are currently on the market; spike wave, asymmetrical 
square wave and symmetrical square wave. Spike wave is the most 
economical of these; it requires battery power only to raise it to its 
peak, with a natural exponential fall-off. As TENS use for relieving 
symptoms of an osteoarthritic knee would be regular and longterm, the 
most economical waveform is desirable. Spike wave of pulse width 80 
microseconds, (fixed) - set at half maximum amplitude with 500 ohms 
resistive load, is used in this experiment (FIG. 4A). This is the 
fixed spike wave shape for the Neuromod Selectra. 
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Representative diagram 
only. 
    
FIG. 4A Spike Wave used for this experiment 
4.1.2 TENS current can be delivered by a variety of electrodes. The 
most common electrodes presently used are made of carbon - rubber, 
with a silicone component to facilitate current flow. Electrodes can 
also be cut from inert metal, to any desired shape. A variety of jacks 
are available to apply electrodes in one or two channels. A contact 
medium is necessary to safely facilitate current passage; water 
soluble gel or wet sponge pads are most common depending on electrode 
choice. TENS electrodes can be self-adhaesive (using a chloride - free 
gum polymer interface), but the experimentation needed to establish 
safe user guidelines for these, is not well documented (Lampe & 
Mannheimer 1984). 
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FIG. 4C Strength - Duration Curve showing stimulation intensities 
necessary for analgaesic levels of stimulation using High 
Rate and strong Burst Mode TENS. 
4.3 The Accomodation Effect 
As a nerve accommodates to a constant current, the potential 
difference experienced across the nerve due to the current flow no 
longer excites the nerve fibre. The potential difference will be 
maintained if the nerve is subjected to a sudden increase or decrease 
in applied external current. Scott (1969) says "a current which rises 
or falls suddenly in intensity is more effective in initiating an 
impulse than one which changes slowly. If the variation of current is 
gradual, there is time for accommodation to take place, and a greater 
intensity is needed to be effective.... A current that changes very 
slowly does not initiate a nerve impulse." In clinical TENS 
application, maintainance of perceived stimulation should occur by 
periodically increasing the intensity of the current (FIG. 4C). 
4.4 Transcutaneous Electrical Nerve Stimulation in a Clinical Setting 
4.4.1 TENS can be applied as a clinical assessment or treatment, or 
at home for regular pain relief. Assessing TENS actions in a purely 
clinical setting poses problems. Wolf, Gersh & Kutner (1978) suggest 
that clinical physiotherapists do not have the time or training to 
monitor TENS parameters in their everyday practice. "They need a 
definitive guide to settings that are successful for individual 
conditions". Wolf & Gersh (1985) and Mannheimer (1987) also suggest, 
that to stablish a fuller understanding of the effect of TENS current, 
objective measures of joint performance, changes in blood flow and in 
functional ability should be documented. 
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Although the experimentation is sparce, and this issue disputed, it 
must be noted that some writers consider that chronic pain patients 
often do not have an adequate diet, may not have normal amounts of 
exercise to metabolise what food they ingest and may suffer from 
endogenous depression [Falk 1982, Phillips (1983)]. Falk (1982) and 
Ward, Bloom & Friedel (1979) suggest that for the most successful 
application of TENS, a chronic pain sufferer's diet should be 
reviewed, (Vitamin B3 intake in particular), his energy expenditure 
monitored, and his mental state assessed to indicate his pain 
threshold and his level of depression. Mannheimer (1987) concurs, 
saying that the areas of diet, pain induced depression, and self 
motivation, are not well understood. 
4.4.2 High Rate TENS Action on Osteoarthritis. 
High Rate TENS (70 - 100 Hz) has been well documented as being 
effective for osteoarthritic conditions. Shealy, Beckner & Prieto 
(1974) and Ersek (1977) spoke of the Pain Gate Blocking effects of 
this TENS mode for chronic musculoskeletal pain, while studies on the 
effects of High rate TENS on osteoarthritis have been noted by 
Thorsteinsson et al (1977), Frampton (1982), Hughes et al (1984), 
Paxton (1980), Wolf et al (1981), Moore & Blacher (1983), Melzack et 
al (1983), Wolf & Gersh (1985). "TENS may be an important adjunct in 
the rehabilitation of arthritic patients, especially when joint 
replacement is not possible" (Wolf & Gersh 1985). 
The efficacy of High Rate TENS on osteoarthritis of the knee is 
discussed by Mannheimer et al (1984), Smith et al (1983) Taylor et al 
(1981), Thurin, Meehan & Gilbert (1980) and Dougherty (1979). 
Although the effects of High Rate TENS as a pain relieving mechanism 
were indicated by these experiments, variations in application 
parameters, and pain relief results, suggested that further testing 
could be supported. In particular, the variation in length of pain 
relief experienced after stimulation ceases, continues to be 
unexplained. It is suggested that the most effective stimulation 
intensity is at tolerable levels, creating a constant tingling feeling 
radiating through the entire painful area (Mannheimer 1987). 
High Rate TENS may mediate osteoarthritic pain by superimposition 
of stimuli, disruption of pain patterns and/ or endogenous opiate 
induction. Cyriax (1977) and Apley (1977) suggest that osteoarthritic 
pain can be separated into A - delta and C fibre componants, emanating 
from damaged bone, capsule, ligament, cartilage and periosteum. Nolan 
(1987) states, "it is still impossible to state categorically the 
exact actions of afferent fibres". Thus the pain mediating effects of 
High Rate TENS with respect to the specific pain of osteoarthritis are 
still unclear. 
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4.4.3 Low Rate or Burst Mode TENS Action on Osteoarthritis 
Although acupuncture is well known for its chronic pain relief 
(Mann 1987), there appears to be little written about the action of 
either Burst Mode or Low Rate TENS on osteoarthritic conditions. 
Indeed, the action of these currents for any condition is poorly 
documented (Wolf & Gersh 1985). Although Low Rate TENS currents are 
recognised for creating intrinsic opiate stimulation, the length of 
treatment time and the intensity necessary for maximum results appear 
to have defused most interest. It has been established that Low Rate 
TENS increases B-endorphin levels in plasma and Cerebrospinal Fluid 
after 25 - 30 minutes [SjOlund & Eriksson (1979), Terenius (1979), 
Wilkes et al (1980)]. A slow rise occurs in pain threshold, which 
remains high for some hours, then slowly returns to normal (Mannheimer 
& Carlsson 1979), painting a picture of systemic time-release of a 
potent endogenous opiate. 
Low rate TENS currents (2-3 Hz) have a different action from 
High Rate TENS. This current is not selectively seeking large fast 
acting afferent fibres. It requires the involvement of neuromotor 
junctions, in order to stimulate endorphin production by repeated 
stressful stimuli. Possible direct neural effects of Low Rate TENS 
have been poorly addressed. Lundberg (1984) allows that while Low 
Rate TENS is known for its potent chemical pain mediation, it may also 
create neural pain mediation via direct action on pain receptors. 
There has been little experimentation done in this area, and pain 
relief mediated by Low Rate TENS has been mostly explained by the half 
life of intrinsic opiates rather than by any other mechanism. 
Mannheimer (1987) notes that the intensity, the strong muscle 
contraction and the length of Low Rate TENS necessary for pain 
mediation, may render it unsuitable for application to an inflammed, 
painful joint. He promotes the use of the recent Low Rate TENS 
adaptation - strong Burst Mode TENS, for patients with chronic joint 
pain. While low intensity Burst Mode TENS can be used as to produce a 
High Rate TENS effect, the strong, pulsing application of this current 
mimics the effects of Low Rate TENS. It causes the strong rhythmic 
muscle contractions necessary to produce the Low Rate TENS-type 
stimulation of the endogenous opiate mechanisms, but does so at more 
comfortable intensities. It can be tolerated well for the 30 or more 
minutes necessary to trigger intrinsic opiate mechanisms (SjOlund & 
Eriksson (1978). 
Burst Mode TENS used in this study comprises train pulses generated 
at 3Hz, with an internal pulse frequency of 80Hz (Medtronic 1984). The 
peripheral nerves recognise the carrier wave as Low Rate pulses, while 
the skin allows passage of the higher frequency train pulses, with 
less resistance than to single Low Rate pulses (Wolf 1984). The muscle 
spindles also react at lower thresholds to the train of faster pulses 
than it does to the slower single Low Rate pulse. Thus the muscle 
contraction necessary for intrinsic opiate action is able to be 
stimulated by lower current amplitudes than for pure Low Rate TENS, in 
a more comfortable application, yet producing the same physiological 
and biochemical effects [Mannheimer (1987), Eriks son et al (1979)]. 
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Table 4.1 Initial Stimulation Parameter Settings of Low Rate and 
strong Burst Mode TENS currents (reproduced Mannheimer & 
Lampe 1984) 
1 
1 	!Low Rate TENS 
7 	 'Frequency ! 1 - 4 Hz 
1 1 !Pulse 	1 150 - 250 millisec 
Iduration I 
!Amplitude' At or above tolerance, 
producing strong, rhythmic 
muscle contractions. 
30 - 80 mA  
1 Strong Burst Mode TENS: 
1 2 - 4Hz 
100 - 200 millisec 
To tolerance, 
producing strong, 
rigthmic muscle 
contractions. 
30 - 60mA 
hction 1 On intrinsic opiate mechanisms after 30 mins, and possibly 1 1 local peripheral synapses. 
The use of tricyclic antidepressants (such as amitriptyline) in the 
treatment of osteoarthritic pain is a current trend [Calabro (1986), 
Altman (1986)]'. One of the roles of this class of drug is to 
stimulate the central release of endogenous opiates. As Low Rate TENS 
has this effect, it seems reasonable that Low Rate TENS (or 
adaptations of it) may also be successful in producing viable pain 
relief for osteoarthritis sufferers. "The-role of clinically induced 
endorphins and enkephalins in relief of osteoarthritis pain is 
recognised, but as yet unclarified" (Altman 1986). Ward, Bloom & 
Friedel (1979) and Falk (1982) suggest that Low Rate TENS 
effectiveness could be enhanced by the prescription of trycyclic 
antidepressants. As High Rate TENS production of endogenous opiates is 
unsubstantiated, an area of research using TENS frequencies and 
trycylic antidepressants may be indicated. 
Low Rate (and its adaptation Burst Mode) TENS cause changes in 
tissue as a result of its stimulation of muscle fibre and blood 
supply. The physical effects of its application to local tissues have 
not been well addressed in the literature. The pain mediating effect 
of muscle activity, change in local blood supply, and change in 
chemical composition around joints as a result of muscle activity are 
not well researched. Altman (1986) suggests that one of the possible 
mechanisms of pain production from an osteoarthritic knee is the 
synovial membrane inflammation. Although such inflammation may be 
directly related to mechanical irritation from joint laxity or loose 
fragments, it may also be due to chemical changes "such as the release 
of collagen, proteoglycans, or enzymes from the damaged cartilage, 
which in turn may activate synovial mediators of inflammation, such as 
prostoglandins or interleukins". It seems possible that local actions 
of induced endogenous opiates via Low Rate TENS mediation may block or 
reverse some of these toxic changes [Inversen (1979), Handwerker 
(1980)]. 
11. Primarily large (proprioceptive) 	1. 
afferent fibre stimulation (narroui 
pulse width and high pulse rate). 
12. Produces a comfortable 
parasthaesia without muscle con- ! 
traction. (not as effective below I 
1 	perception level). 
1 
0. Fast onset (accommodation occurs I 3. 
needing amplitude readjustment). I 
k. Relatively short aftereffect 	1 4. b. Little or no endogenous opiate 	t 5. 
liberation. 
. No reversal by naloxone 	6. 
7. Primarily local CNS effects 	7. 1 18. Stimulation by surface electrodes 8. 
in segmentally related regions is 
most effective. 
I 2. 
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Table 4.2 A Physiological Comparison of High and Burst Mode TENS 
rHigh Rate TENS 	 1 Strong Burst Mode TENS 
1 
Primarily small (pain) 
afferent and (motor) efferent, 
fibre stimulation (narrow 	1 
1 
1 
Slow onset (little or no 	1 
accommodation. May activate 
summation mechanisms). 
Relatively long aftereffect I 
Endogenous opiate liberation I 1 
Reversal by naloxone 
Primarily higher CNS effects 1 
Stimulation by surface elect-1 
rodes in segmentally related, 
myotomes is more effective. i 
4.5 Parameters involved in TENS Application for Osteoarthritic Knees 
Research into the specific variables in TENS therapy for 
osteoarthritic knees is far from completed. Wolf et al (1981) warned 
"that the lack of specific investigation into optimum electrode 
placements and stimulation parameters casts doubt upon the efficacy of 
TENS". Factors such as current flow, skin / electrode impedance, 
inter-electrode distance, frequency of stimulation, pulse shape and 
width, length of treatment time and differences in body part reactions 
to TENS remain largely unexplored. Grau (1981) suggests that 
frequency, intensity and duration of current are critical to 
analgaesia production. Mannheimer & Carlson (1979) suggest "TENS gives 
pain relief in a number of conditions. The underlying mechanism is not 
clear. Consequently the choice of optimal stimulation variables must 
be based on clinical experience." Wolf & Gersh (1985) urge further 
study. "Specific electrode placements and stimulation characteristics 
must be evaluated in relation to specific disease entities, to 
establish more effective treatment protocols". 
4.5.1 Length of the Experiment 
The length of this experiment was indicated by recent studies. 
[Mannheimer & Lampe (1984), Thurin et al (1980), Dougherty (1979), 
Smith et al (1.983), SjBlund & Eriksson (1976)]. 30 minutes Burst Mode 
TENS is necessary to stimulate endomorphin production. Although 
blocking neural pathways occurs immediately with High Rate TENS, 
longer applications of High rate TENS may be necessary to stimulate 
more lasting forms of analgaesia (Lundberg 1984). As one of the aims 
of this experiment was to establish TENS as a viable form of post 
stimulation analgaesia for osteoarthritic pain, it was felt that 30 
minutes stimulation was necessary to produce a definitive result. 
pulse width and low 
pulse rate). 
Produces a strong muscle 
contraction. Effectiveness 
increased by highest 
tolerable contractions. 
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4.5.2 Stimulation Levels used in This Experiment  
4.5.2.1 High Rate TENS 
Studies by Walmsley & Flexman (1979), and Andersson et al (1976) 
established that experimental High Rate TENS produces immediate pain 
relief over a range of intensities. Intensities set from "just above 
sensation threshold" to "at and above patient tolerance" all produce 
pain relief (Andersson et al 1976). As there was no necessity to 
increase the discomfort of the subjects in this trial, the commonly 
accepted stimulation level of High Rate TENS application has been used 
for this experiment. Mannheimer (1987) defines it as "a 	_ _ 
tolerable tingling (pins and needles) sensation (without muscle 
contraction) perceived throughout the area of the pain". 
4.5.2.2 .Burst Mode TENS  
While early research [Andersson & Holmgren (1975), Holmgren 
(1975)] suggested that the intensity of Low rate TENS must be 
uncomfortable in order to stimulate increases in endogenous opiate 
production, later development of Burst Mode TENS to mimic a Low Rate 
current indicates that tolerably strong, repetitive stimulation 
producing muscle contraction will also create prolonged pain relief 
[Fields & Basbaum (1978), Fields & Andersson (1978)]. Again, there was 
no need to increase the discomfort of the subjects participating in 
this study, so the Burst Mode TENS option was used in preference to a 
pure Low Rate TENS application. Maintaining a strong muscle 
contraction around the knee was essential throughout this TENS 
application; such stimulation has been shown to produce a sustained 
neuronal discharge to the Nucleus Rophe Magnus and the Periaqueductal 
Grey (Eriksson et al 1979). 
4.5.3 Electrode Placement  
The type and extent of pain is the common guide to electrode 
placement for osteoarthritic knee treatment, although the position and 
size of electrodes, the type of electrode used and the direction of 
current flow are not often noted in the literature. While Low Rate 
TENS electrodes are usually placed over acupuncture points (see 
Section 5.2), High Rate TENS electrode placements for specific 
conditions [Wolf & Gersh (1985), Lampe (1984)] seem no more defined 
than those developed with early TENS therapy [Shealy (1974), Ersek 
(1977)]. The prevailing criteria seems to be that the electrodes be 
placed in such a way as to stimulate the local cutaneous nerve supply, 
and to cover as much as possible of the painful area. Mannheimer 
(1978) contends that there is a basic problem when deciding on common 
stimulation points; "using the same specific electrode placement sites 
for different patients with similar conditions is not always 
effective." He suggests that the selection of stimulation sites 
depends on "an awareness of etiology, location and character of the 
pain", and as this is individually mediated, it may be at this stage 
where research can no longer be specific. 
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Linzer & Long (1976) and Laitinen (1976) suggest that electrode 
placement is the most important parameter in TENS mediated pain 
relief. Several methods of application are demonstrated in the 
literature for applying High Rate TENS electrodes for the relief of 
osteoarthritic knee pain. 
1. Painful skin sites were used by Berlant (1984), Melzack (1976), 
Melzack et al (1977), Smith et al (1983) and Taylor et al (1981). 
2. Superficial points on peripheral nerves around the knee were used 
by Smith et al (1983), Dougherty (1979) and Mannheimer et al 
(1984). Those chosen were medial crural nerve, anterior femoral 
cutaneous nerve, lateral femoral cutaneous nerve and posterior 
femoral nerve. 
3. Piggybacking multiple electrodes to stimulate wider cutaneous 
areas and deeper nerve plexuses is suggested by Mannheimer 
(1978), Wolf, Gersh & Kutner (1978) and Medtronic (1982). 
4. Acupuncture points for relief of osteoarthritic knee pain are 
described by Mannheimer et al (1984), Smith et al (1983) and 
Thurin et al (1981). Points on Spleen, Gall Bladder, Kidney, 
Urinary Bladder and Liver meridians were used to stimulate the 
knee. 
5. Motor points, sites which are characterised by high electrical 
conductance and low skin resistance (Goodgold & Eberstein 1978), 
are suggested by Medtronic (1982) and Mannheimer & Lampe (1984). 
Electrode placement over Spleen 10 coincides with a motor point 
of Vastus the medialis muscle, while Urinary Bladder 40 is a 
motor point of the Popliteus muscle. 
4.5.4 Electrode Placement Choice for This Experiment 
4.5.4.1 The choice of acupuncture points for electrode placement in 
this study was made because 
1. acupuncture points make clinical anatomical placement better 
defined, and thus able to be reproduced, 
2. by applying High Rate and Burst Mode TENS current to the same 
anatomical points it was hoped to maximise any analgaesia via 
the endomorphin mechanisms of the two TENS frequencies. 
It is acknowledged that the electrodes used in this study would 
stimulate not only the exact acupuncture point, but also the other 
anatomical issues noted in 4.5.4.2, because of the electrode size. The 
electrodes available on the present TENS market do not allow 
stimulation of acupuncture points alone. Manufacture of smaller and 
safer surface electrodes is to be encouraged. 
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4.5.4.2 The acupuncture points chosen for this study are Spleen 9, 
Spleen 10, Urinary Bladder 33 and Gall Bladder 40. A 
description of the acupuncture points used in this 
experiment is found in Section 5.3. These points represent 
1. points on four sides of the knee, thus providing irradiation 
of the entire joint (Ersek 1977), 
2. common painful spots found in osteoarthritic knees [Taylor et al 
(1981), Berlant (1984)], 
3. two motor points of muscles around the knee (Gunn 1976), and 
4. stimulation of the cutaneous nerves which surround the knee 
(Gray's Anatomy 1972). 
4.5.5 Current Flow 
Parallel current flow between two channel electrode placements is 
discussed in Mannheimer (1978), Wolf, Gersh & Rao (1981), Mannheimer 
& Lampe (1984), Mannheimer (1987) and Medtronic literature (1982, 
1984). Parallel currents are inherent in the original TENS theory 
and have been well documented (Shealy 1974). The current runs in the 
same direction as the cutaneous nerves that supply  the knee. As is 
illustrated in FIG. 4D, current runs between Spleen 9 and 10 
electrodes, and between Urinary Bladder 40 and Gall Bladder 33. 
I . 
Spleen 941-iiI0 
2. 
Urinary Bladder 
404—,Gall Bladde 
33 
FIG. 4D 	Current Flow in this Study 
4.6 Conclusion  
The choices presented to those who prescribe and apply TENS for the 
relief of chronic osteoarthritic knee pain are abundant. What provides 
the most successful pain relief will be informed combinations within 
the available parameters. Advances in TENS technology may provide even 
more parameters from which to choose. It is vital that those who use 
this powerful modality understand the rationale of each of the 
parameters involved in TENS application, and are able to apply them to 
individual conditions. 
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ACUPUNCTURE POINTS: APPLICATION FOR OSTEOARTHRITIC KNEES  
5.1 Acupuncture has enjoyed increasing Western world acceptance, 
following cultural exchanges resulting from the Chinese Cultural 
Revolution. Despite continuing scepticism from many traditional 
sections of the medical community (Mann 1973), acupuncture and/or use 
of acupuncture points is practiced successfully by doctors and 
paramedics for many painful and irritating conditions (Levine, 
Gormley & Fields 1976). Although acupuncture has been used 
succesfully in acute pain relief like headache (Melzack, Stillwell & 
Fox 1977), and childbirth (The Academy of Traditional Chinese Medicine 
(1975), it is suggested that acupuncture may have its greatest impact 
on modern medicine in the treatment of chronic pain [Mann, Bowsher, 
Mumford, Lipton & Miles (1973), Mann (1987), Melzack & Fox (1976)]. 
The characteristics of acupuncture points suggest that their use in 
all clinical applications of TENS is strongly indicated; the common 
acupuncture points are well documented, they are easily identified 
and reproduced, they overlie many superficial nerve roots and sensory 
nerve endings, and they have a high correlation with established 
medically used trigger and motor points. 
5.2 Use of Acupuncture Points in TENS Applications for Osteoarthritis 
Despite being described by Smith et al (1983) in a High Rate TENS 
experiment for osteoarthritic knee pain, acupuncture points are not 
the presently accepted choice for electrode placement for High Rate 
TENS administration to osteoarthritic joints. Because of the 
traditional understanding that High Rate TENS works mainly on the Pain 
Gate (Mannheimer & Lampe 1984), electrode placements are usual over 
spinal nerves, nerve pathways, painful spots, motor points or trigger 
points. Because it evolved from the theory of acupuncture, Burst Mode 
(or Low Rate) TENS must be applied to acupuncture points for the 
successful relief of chronic pain [Anderson, Eriksson & Holmgren 
(1973), Andersson & Holmgren (1975), Melzack (1976), Wolf & Gersh 
(1985)]. 
The acupuncture points used for Low rate TENS administration have 
been strongly correlated with trigger points and cutaneous nerve 
pathways used for High rate TENS administration [Mann (1987), Gunn & 
Milbrandt (1975), Melzack, Stillwell & Fox (1977)]. It seems logical 
to question whether High rate TENS, applied over traditional 
acupuncture points, may also stimulate the endorphin activity, 
currently associated with Low Rate TENS and acupuncture. Paxton (1980) 
suggests that wide-spread maximally effective use of TENS for chronic 
pain may require another 30 years study and education, while Altman 
(1986) suggests that "the role of clinically induced endorphins and 
enkephalins (via pharmacological or electrical agencies) in relief of 
osteoarthritic pain is yet to be clarified". It appears that 
the issue of endorphin production via TENS current over specific 
electrode placements is still to be fully addressed. 
Spleen 9 	 Spleen 10 --1, • 
Scale: approx I in 15 
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5.3 Acupuncture points Chosen for This Study 
Descriptions of the points are reproduced from Essentials of 
Chinese Acupucture (1980) and Mann (1987). 
5.3.1 Yinlinqquan (Spleen 9) (He - Sea Point) 	(FIG 5A) 
(Represents trigger point of medial aspect knee (Scott 1969)). 
Location: 
Vasculature: 
Innervaton: 
Indications: 
On the lower border of the medial condyle of the tibia, 
in the depression between the posterior border of the 
tibia and gastrocnemius muscle. 
Anteriorly, great saphenous vein, genu suprema artery. 
Deeper, the posterior tibial artery and vein 
Superficially, the medial crural cutaneous n., 
Deeper, tibial n. 
Abdominal distension, oedema, jaundice, diarrhea, 
incontinence, dysuria, pain in the knee. 
FIG 5A Spleen 9 	 FIG 5B Spleen 10. 
5.3.2 Xuehai (Spleen 10) 	(FIG 5B) 
(Represents motor point of Quadriceps vastus medialis (Scott 1969)). 
,) 
Location: 	When the knee is flexed, the point is 4 cm above 
mediosuperior border of the patella, on the bulge of the 
medial portion of quadraceps muscle. Cup R hand to the 
patient's L knee, Thumb on the medial side - the point 
is at the tip of the extended thumb. 
Vasculature: Muscular branches of femoral artery and vein 
Innervation: Ant. Femoral cutaneous n., muscular branch fem. n. 
Indications: pain in anterior / medial aspect thigh and knee 
Gall Bladder 33 
Urinary 
Bladder 40 
Scale: I in 15 approx. 
Scale: i'in 
10 approx. 
FIG 5C Urinary Bladder 40 	FIG 5D Gall Bladder 33 
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5.3.3 Weizhonq (He - Sea Pt) (Urinary Bladder 40)(FIG 5C) 
(Represents trigger point at posterior knee (Scott 1969)). 
Location: 	Midpoint of transvese crease of the popliteal fossa, 
between tendons of biceps femoris muscle and 
semitendinosis m. Locate in prone or with a flexed knee. 
Vasculature: Superficially - femoropopliteal vein, popliteal vein, 
popliteal artery. 
Innervation: Posterior femoral n., tibial n. 
Indications: Low back pain, motor impairment of hip, contraction of 
tendons of popliteal fossa, motor impairment and pain in 
lower extremities, muscular atrophy. 
5.3.4 Xiyanqquan (Gall Bladder 33) (FIG 5D) 
(Represents trigger point lateral aspect lower femur (Scott 1969)). 
Location: 	Knee flexed, point is 6 cms above head of fibula lateral 
to the knee joint, in the depression between tendon of 
biceps femoris m. and the femur. 
Vasculature: Superior lateral genicular artery. 
Innervation: Terminal branch of lateral femoral cutaneous n. 
Indication: Pain and swelling in the knee, contracted tendons in 
the popliteal fossa, numbness in the leg. 
CHAPTER 6 	 39. 
SUBJECTIVE AND OBJECTIVE ASSESSMENT OF OSTEOARTHRITIC KNEES 
6.1 Chronic Osteoarthritic Joint Assessments 
Sufferers from osteoarthritis of the knee experience discomforts 
that are difficult to measure experimentally. To gain a full 
appreciation of the effects of TENS on osteoarthritic symptoms, all 
areas of osteoarthritic dysfunction must be examined. Osteoarthritic 
pain has been mentioned already. Stiffness also is a well documented 
problem of osteoarthritis [Altman (1986), Calabro (1986)], as is 
muscle dysfunction, joint swelling and decrease in range of movement 
(Darby 1983). Pain, stiffness, joint swelling and range of movement 
may be inter-related; a change in one may create a change in another. 
For TENS to be proven effective for relief of chronic osteoarthritic 
symptoms, wider subjective and objective measures must be taken. 
Sternbach (1976) suggests that "pain assessment based entirely on 
the patient's description of pain is a procedure that invites 
contamination and confounding by both psychological and sociocultural 
factors." Procacci, Zoppi and Maresca (1978) express wariness of 
sensory matching techniques because of the extra variables and 
psychological reactions caused by externally induced pain. Von 
Knorring, Almay & Johansson (1978) suggest that a patient with chronic 
pain may have a different reaction to TENS than one with no pain, 
because of changes in personality and expectation. Werner (1980) 
illustrates two components of pain; "the interpretive/ emotional 
component and the localizing/sensation component" that must be 
addressed to gain full insight into individual pain states. By dealing 
with subjects with chronic pain, as this study did, it was thought 
that the emotional component may be controlled; the chronic 
osteoarthritic knee would have limited the subject's lifestyle, 
created an expectation of pain and limitation in joint function at 
some stage in each day, and induced caution in attempting any physical 
exertion that may stress the knee (NH & MRC Report 1988). 
TENS literature on chronic osteoarthritic pain to date has been 
limited by the measurements taken. Descriptive and/or numeric pain 
assessments, and varied indices of functional activity were the only 
measurements taken in the TENS and osteoarthritis literature reviewed 
for this study. TENS is considered to have been effective if it 
decreases the subject's immediate pain measurement by 50 percent. 
[Hansson & Ekblom (1983), Salar, Job, Minguino, Bosio & Trabucci 
(1981)]. Wolf & Gersh (1985) are critical of TENS literature to date: 
"most investigators still rely on the patient's report of pain to 
establish the efficacy of TENS treatment". Physical measures such as 
"joint range, strength, muscle girth" would enhance "established 
objective evaluation of TENS efficacy". 
6.2 Measurements For This Study  
When considering the measurements required by this study, several 
factors had to be considered: 
1.the time taken to administer the test, 
2.the degree of difficulty experienced by the subjects when 
completing the reqirements of the assessment, 
3. the need to control the degree of complexity of this study, 
4. the limitations of both the study and the measurements, and 
5. the reliability of the measurements (see Section 6.2.2.1). 
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This study measured pain and stiffness (immediately and over time), 
and immediate post test knee circumference and range of movement to 
validate the effects of the TENS frequencies on osteoarthritic knees. 
Measurements taken were: 
1. a quantitative measurement of a change in pain state, 
2. a report of pain relief over 24 hours, 
3. a quantitative measurement of change in stiffness state, 
4. a report of stiffness relief over 24 hours, 
5. objective circumference measurement immediately pre/post test, 
6. and objective range of movement measurement immediately pre/post 
test. 
6.2.1 	Subjective Measurement - Pain and Stiffness  
A number of choices were available in the area of subjective 
assessment of pain. This study included a measurement of stiffness as 
well as pain, although there is no precedent in TENS literature for 
measuring this. Stiffness is not necessarily a subjective assessment, 
although neither does it fall into an objective category. Measuring it 
subjectively highlighted clinical anomalies. Some joints were stiff 
only in one range, while others were stiff only at certain times of 
the day. To clarify this issue, subjects were asked for a measure of 
whether their immediate overall stiffness had improved with TENS 
current, and if so, by how much. It was felt that by conducting the 
measurements over 24 hours, variations in patterns of stiffness could 
be addressed. 
The choices for assessing pain range from descriptive 
questionaires [Melzack (1975), Tursky (1976)], body diagrams (Kopala & 
Matassarin-Jacobs 1984), sensory matching (pain to pain), [Kast 
(1966), Sternbach (1974), sensory matching (pain to colour) (Stewart 
1977), to Descriptive Pain Indexes [Ingham (1969), Stewart (1977)]. 
Several mutifaceted choices are available which are supposed to 
completely address the chronic pain state [Mannheimer & Lampe (1984), 
Hendler, Viernstein, Gucer & Long (1981), Shealy & Shealy (1976)]. 
These pain assessment methods were considered too detailed and too 
time consuming for the needs of this experiment. 
The confines of the study, the need for quantitative measures of 
both immediate pain and stiffness change, and simplicity of 
application directed the choice to scale measurement. Although it may 
have been easier for the subjects to use Descriptive Scales [Stewart 
(1977), Melzack (1975), Johnson (1972)] or Numeric Scales (Stewart 
1977), the choice for the Absolute Visual Analogue Scale was made 
because of its greater validity (see Section 6.2.2.1). 
6.2.2 The Absolute Visual Analogue Scale  
A pure line scale was used in this experiment. No graphic rating 
was indicated, and two scales were used side by side to describe pain 
and stiffness. The only descriptions used were "No Pain (Stiffness)" 
at the left (bottom) of the scale, and "Pain (Stiffness) as bad as you 
have aver had it" at the right (top). The subject marked his pain and 
stiffness estimations along vertical 10 cm lines, with readings taken 
with an accuracy of one decimal point (Scudds 1983) (FIG. 6A). 
No Pain  	Pain as bad as 
you have ever had it 
FIG. 6A Absolute Visual Analogue Scale 
41. 
The vertical configuration used in this study (seen in Appendix 2) 
was chosen with regard to argument as to preferred alignment [Stewart 
(1977), Downie, Leatherman, Rhind, Wright, Branco, Anderson (1978), 
Scott & Huskisson (1976)]. It was hoped that ease of using the scale 
may be enhanced by its likeness to a thermometer (Zussman 1986). 
It was accepted that it may be difficult for some patients to 
transfer their pain and stiffness sensations into visual and linear 
dimensions, and that the abstract quality of the visual analogue scale 
may frustrate some test subjects (Kremer, Atkinson & Ignelzi 1981). 
The subject's visual and motor coordination was essential, as was "the 
ability to place a mark where he (the patient) intends to put it." 
(Revill et al 1976). Potential subjects who suffered from autism or 
dementia were considered unable to use this scale (Merskey 1974). 
6.2.2.1 Advantages of AVAS  
The advantages of the scale as accepted by this author are: 
1. It is easily administered (Zussman 1986) and therefore 
suitable to a clinic application. Its simplicity and lack of 
descriptive direction made it an ideal experimental assessment 
tool. 
2. Pain and stiffness estimation can be reproduced and is 
reliable over time (Revill et al 1976). 
3. Statistical inferences can be drawn because the scale is not 
tied to graphic descriptions, thus avoiding the inequal internal 
comparison (Stewart 1977). 
4. The 10 cm line is acceptable for statistical error (Revill et al 
1976). 
5. The scale is sensitive to pain and stiffness change (Clarke & 
Spear 1964). 
6. It "does not force quantum changes in pain intensity as 
occurs with category scales" (Ohnhaus & Adler 1975). 
7. The patient choices are not limited by 
a) lack of appropriate descriptive words (Price, McGrath, Rafii & 
Buckingham 1983) as in McGill-Melzack Study. 
b) having to read and understand English 
c) having to engage in, or rate Activities of Daily Living for a 
total pain assessment. This limits fear, anxiety, disinterest, 
clinically produced pain and associated musculoskeletal 
disorders which may intensify reactive pain (Linton 1985). 
6.2.2.2 Disadvantages of AVAS  
The disadvantages found with the scale in this study were: 
1. It did not address pain differentiation ability between subjects. 
Some asked whether the scale represented the soreness or the ache 
felt in the affected knee joint. 
2. The scale did not allow for different pain intensities depending 
on subject's position; eg it was noted that pain varied depending 
on posture, weightbearing, clothes being worn and the weather. 
This was addressed by taking all AVAS measurement in weight-
bearing, before and after the test, with the knee unclothed. 
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6.2.3 Verbal Reports of Pain and Stiffness  
Verbal reports of length of pain and stiffness relief have some 
precedent in TENS literature [Smith et al (1983), Taylor et al 
(1981), Dougherty (1979), Mannheimer et al (1984)], although the 
possibility of inaccuracy is inherent. However, Altman (1986) suggests 
that chronic sufferers of osteoarthritis of the knee are capable of 
being accurate when recording the diurnal variations of their pain. 
They learn over time to accommodate their daily activities to their 
pain state. Subjects were asked to indicate when, over a 24 hour 
period, their pain and stiffness levels, produced by the TENS trial, 
returned to "normal". 
6.2.4 	Objective Measurement  
The objective measurements chosen for this study were those 
relating to changes in knee joint function after TENS application 
(Twomey 1979). The measurements would reflect local changes that may 
be caused by alteration in blood supply, changes in synovial activity, 
decreases in swelling and any local blocking activity that may occur 
with intrinsic opiate action. 
6.2.4.1 Goniometer (FIG. 6B) 
The use of the goniometer to measure changes in joint range was 
developed by Gifford (1914), during the First World War. Its uses have 
been considerably advanced since then [Rosen (1922), Moore (1949), 
Joshi, Singh, Kanta & Varma (1978)], although the standard goniometer 
remains a simple, easily used guide to knee joint movement. Twomey 
(1979) suggests that its measurement error is 1 degree. The use of a 
goniometer is supported in the TENS literature as a guide to objective 
joint improvement as a result of applying TENS (Medtronic 1984). 
6.2.4.2 Tapemeasure  
The use of a tapemeasure to measure changes in joint 
circumference has been well established [Apley (1978), Jacox (1977), 
Corrigan & Maitland (1986)]. It is an accurate and simple form of 
measuring physical changes in knee joint behaviour. This author allows 
an error of 0.5 cm when measuring around the joint line. To 
facilitate correct re-measuring after the test, ink lines were 
drawn on the skin at the top of the tape during the pre-test 
measurement. The tapemeasure was subsequently realigned with these 
marks for remeasuring. 
Seale: I in 1.5 
FIG. 6B The goniometer used in this study 
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CHAPTER 7 
THE STUDY 
7.1 Intervention (Study Factor) 
This double blind experiment tested whether, when compared with 
High Rate TENS and a placebo, strong Burst Mode TENS produced 
significantly greater symptomatic change in chronically painful 
osteoarthritic knees. All TENS frequencies were applied to the same 
four acupuncture points for 30 minutes of constant, tolerable 
stimulation. 
Any changes resulting from the application of Burst Mode TENS, High 
Rate TENS and placebo were measured by: 
1. pain change on an Absolute Visual Analogue Scale (AVAS): 
readings taken immediately before and after the test, 
2. stiffness change on an AVAS: readings taken as for 1., 
3. pain relief time (in hours) after the test, 
4. stiffness relief time (in hours) after the test, 
5. change in knee circumference: readings taken immediately before 
and after the TENS test, 
6. change in knee joint range of movement: readings taken as for 5.. 
The subjects were tested in supine, with a small towel supporting 
the knee in approx. 15 degrees flexion. The four electrodes used were 
connected in parallel dual channels. All instructions were given, and 
measurements taken, by S.C., a typist, who was trained by this author 
in the protocol and measuring skills required for the study. S.C. was 
blinded to both the test design and the expected outcomes, and was 
not involved in the allocation of subjects into groups. 
7.2 Subjects 
7.2.1 The Reference Population 
It was considered that all people with chronically painful 
osteoarthritic joints may benefit from this study. Pain relief gained 
from a successful TENS application may reduce medication, reduce time 
lost from work, prolong independence, postpone surgery and reduce 
visits to physiotherapy and allied health professionals. 
7.2.2 The Source Population 
The source population was limited by the small number of replies 
from those doctors contacted to supply subjects for this study. It 
comprised subjects from the following regions of Southern Tasmania. 
The referral sources are listed. ' 
East Coast of Tasmania 	- 1 (referred by Royal Hobart Hospital RHH) 
Tasman Peninsula 	- 2 (referred by Royal Hobart Hospital) 
Northern Hobart suburbs - 19 (ref. RHH & Hobart General Practitioners.) 
Eastern Shore of Hobart - 11 (ref. RHH & Hobart GPs) 
Kingston 	- 12 (ref. Huonville Physio. Clinic & Huon GP) 
Huon/Channel district 	- 31 (ref. Huonville Physiotherapy Clinic, 
Huon District Hospital, Cygnet Physio., 
Dover Annex, Huon GPs) 
Total source population = 76. 
All subjects suffered from painful, chronic osteoarthritis of the 
knee before April 1988. The methods of referral to the 
study are outlined in 7.2.3.2. 
44. 
7.2.3 Obtaining the Study Sample  
7.2.3.1 The study sample size was estimated using the results of a 
pilot study by this author in 1987 (lodged Q'ld University, 
Physiotherapy School), and information from the current TENS 
literature. 
In the pilot study, High Rate TENS produced significantly greater 
and longer lasting pain relief than the placebo, with 20 subjects in 
each test group. Current literature suggests that Low Rate TENS (Burst 
Mode TENS) is expected to produce at least 1.5 X the length of pain 
relief created by High Rate TENS. 
Given the constraints of this study (e.g. finance, time and 
availability of subjects), it was felt that 20 subjects in each group 
(60 overall) may be sufficient to confirm the hypothesis. Once the 
study was begun, it was realised that the small source population, 
obtained from the few replies to the proposed study, would have made a 
larger study impractical to conduct. 
7.2.3.2 	The method of obtaining the study sample was by: 
1. compiling a register of all patients treated for osteoarthritis 
of the knee within the last six months, at the Royal Hobart 
Hospital (RHH) Physiotherapy Outpatient Clinic, the Huonville 
Physiotherapy Clinic, Huon District Hospital (HDH) Physiotherapy 
Department (including Dover Annex), Cygnet Physiotherapy and 
Kingston Physiotherapy, 
2. compiling a register of subjects receiving private medical 
treatment for osteoarthritis of the knee. Letters were sent to 
i). all orthopaedic and rheumatology specialists in Southern 
Tasmania. Total = 7 
ii). General Practitioners in Hobart, Channel Area and Huon 
Valley, randomly selected from the telephone book. 
Total = 13 
TOTAL DOCTORS CONTACTED= 20 
NO. WHO RESPONDED = 7 General Practitioners (359 response 
rate) 
None of the specialists who were contacted for this study 
replied. 
iii). Letters were sent to all Senior Citizens Clubs in Hobart, 
and in the Channel and Huon Areas. 
TOTAL CONTACTED = 8 
NO. CLUBS WHICH RESPONDED = 2; netting 7 possible subjects. 
Those Senior Citizens who replied, were then followed up 
by contacting their General Practitioners, to assess their 
suitability for the test. 
45. 
Table 7.1 The origin of the potential subjects in this study. 
	 -1 
Place of treatment for Osteoarthritis of knee in last 6 months 
(January - June 1988) 	 No. subjects 1 
1 IRegister of O.A. knee patients at Physiotherapy 	 1 
Outpatients Dept., Royal Hobart Hospital. 	1 22 
IHuonville Physiotherapy Clinic 	 ! 20 
'Huon District Hospital I 	9 'Dover District Annex of H.D.H. 6 
1 3 Huon District General Practitioners 	1 7 (including' 
3 from 1 local Senior Citizen's Club) 
14 Hobart General Practitioners 	 1 12 (including1 1 4 from 1 local Senior Citizen's Club.)1 
4 	 1 
'TOTAL !' 76 
Table 7.2 Particulars of potential subjects contacted for the trial. 
particulars 
i pied before the test ) Would have 
I 	 been suitable I 
Refused to take part 	. 
Previous TENS experience: Un- 
o present knee pain 	: suit 
iUnable to use AVAS : able 
Too ill to participate : I 
Number suitable to participate 
h 	  FOTAL 
Male 	Female J  
1 0 
0 	1 
1 1 
5 3 
0 	1 
0 3 
23 	37 = 60 
30 46 = 76 
7.2.3.3 The method of contacting possible subiects was as follows: 
1. The doctor of any subject coming to the trial without referral 
was contacted. The subject's osteoarthritic knee diagnosis was 
confirmed, and permission was asked to involve the subject in the 
trial, should he/she be suitable. 
2. The potential subject was contacted initially by telephone. 
The following items were addressed. 
i. The trial was explained, and it was ascertained whether the 
subject would be willing to participate. 
ii. It was ascertained whether the subject was willing to withold 
medication as outlined in 7.3. 
iii. The length of time and extent of O.A. affliction was 
discussed, whether the subject had present knee pain, whether 
one knee was more painful than the other, and if the patient 
could distinguish individual knee pain. 
iv. It was determined if the subject had previously experienced 
TENS therapy. If the subject or his doctor did not know, the 
subject's physiotherapist was contacted. 
v. A test time, the place and travel arrangements were then 
decided. 
vi. The subject was informed that pain relief should not be 
expected, and that he could withdraw at any time. 
46. 
7.2.4 The Study Sample  
Sixty suitable subjects (23 men and 37 women) were obtained from 
the-76 people contacted. The subjects in the study sample were 35 - 96 
years of age, and had suffered from a chronically painful 
osteoarthritic knee for longer than six months. The possible sex 
frequency of osteoarthritis of the knee has been recognised, and the 
ratio of females to males found in this study (1.6 : 1) seems 
compatible with that indicated in the literature. The subjects and the 
independent measurer were blinded by not knowing into which group they 
were allocated, which TENS frequency was applied, or what were the 
expected outcomes. 
These 60 subjects were randomly assigned by dice into three groups 
of 20. The dice was thrown by an independent observer (J.G„ a typist) 
as each subject was enrolled into the study. Entry into the study 
occurred once all the criteria illustrated in 7.3 were fulfilled. 
J.G. filled out the test sheet (APPENDIX 2) with the subject's name, 
the group into which he/she was allocated, his doctor's name and the 
date and time of the test. 
If the dice fell at 1 or 4, the subject was entered in Group 1. 
Group one was tested with High Rate TENS (80 Hz). 
If the dice fell at 2 or 5, the subject was entered into Group 2. 
Group two was tested with Burst mode TENS (3Hz with trains of 
pulses of 80Hz). 
If the dice fell at 3 or 6, the subject was entered into Group 3. 
Group 3 was the placebo application. 
Each suitable subject's osteoarthritic knee diagnosis was con-
firmed with his doctor's records. In 51 cases the doctor had confirmed 
this diagnosis with X-ray and/or arthroscopy at some time previously. 
In 9 cases, the doctor suggested X-raying the subject, who he 
suspected had the disease, but had not yet had it verified by X-ray. 
All but 4 of the subjects tested were able to independently attend 
the test. These four subjects were tested in Huon District Hospital. 
The reasons for hospitalization were 
1. three subjects with minor heart problems, and 
2. one social admission due to recent bereavement. 
Test venues were established in central places to accommodate local 
groups of subjects, so that travelling did not create a problem. 
47. 
7.3 	Inclusion Criteria for Subject Selection 
1. Osteoarthritis was the only reason for knee pain, and hence 
referral to this study. The osteoarthritic state had been 
confirmed by the subject's doctor and had been diagnosed as 
chronic at least 6 months earlier. The criteria for chronic knee 
pain has been described in NH & MRC Report (1988) on "Management 
of Severe Pain". The subject must have present pain in his knee 
for the test to take place. 
2. The subject's doctor considered him/her fit to participate in 
this study, and had given his consent for the subject to take 
part. No doctor refused permission for his patient to 
participate. 
3. The subject had voluntarily withheld medication for the 
required period prior to, and after the test (See APPENDIX 3) 
a. NSAI medication for 48 hours before the testing period, and 
until the pain and stiffness levels returned to "normal" 
after the study. 
b. Analgaesics for 4 hours prior to the study, and until 
"normal" pain and stiffness levels returned. 
c. Muscle relaxants for 12 hours prior to the study, and until 
"normal" pain and stiffness levels returned. 
4. The subject was not wearing a hearing aid or a pacemaker 
while experiencing TENS current (Eriksson, Schuler & SjOlund 
1978). 
5. The subject was prepared to sign a consent form (APPENDIX 1), 
which indicated that 
i. he/she agreed to participate in the trial of his/her own 
free will, 
ii. he/she was aware that pain and/ or stiffness relief was not 
guaranteed, 
iii. he/she had agreed to attend the test, and to be contacted 
24 hours after the test, and 
iv. he/she could terminate his/her role in the trial at any 
time. All subjects completed the test. 
6. The subject was able to complete visual analogue scales for 
pain and stiffness (APPENDIX 2). In the event that a subject be 
unable to complete the A.V.A.S. without help, the test would 
still take place, but the results would be excluded from the 
survey. All the subjects tested were able to fulfil the 
requirements of the test. 
7. In the case of multijoint involvement with osteoarthritis, 
the subject must be able to distinguish the pain in his/her more 
painful knee. 
8. The subject had no previous experience of TENS current. 
48. 
7.4. Apparatus (Illustrated in FIG. 4B) 
7.4.1 	The Transcutaneous Electrical Nerve Stimulator used in this 
experiment was a Medtronic Neuromod Selectra, producing High Rate 
current of 80 Hz, and Burst Mode current, generated at 3 Hz, of trains 
of 7 pulses with an internal frequency of 80 Hz. It has an easy 
pushbutton method of increasing intensity, and a digital intensity 
display. It is powered by four replaceable AAA batteries. Although the 
life of batteries is greater than 60 hours performance, new batteries 
were used every 10 hours performance for maximum efficiency. The unit 
was independently checked during the trial for constant frequency 
output by Mr. Terry Reagan, of Medical Engineering Pty . . Ltd., Hobart. 
The electrodes and active leads were similarly checked for 
performance. 
7.4.2 Four carbon/rubber/silicon electrodes of 3 x. 4 cm area (FIG. 
7A) were used in a two channel configuration illustrated in FIG. 4D, 
 
ra4----  4c Scale: 1 in 1 
FIG 7A 	Carbon-rubber Electrodes used for this experiment. 
Para Gel was used as a contact medium under all electrodes, and 
Micropore paper tape was used to hold the electrodes in place. 
A Stopwatch, test sheet and pen, couch, pillows, blanket, towel 
for knee support and a quiet room were test requirements. 
7.4.3 The same goniometer was used for all objective range of 
movement measures of the knee (illustrated in FIG. 6B) 
7.4.4 The same tape measure was used for all measurements of 
circumference of the knee around the joint line. 
7.4.5 An appointments system was established, so that the test and 
follow-up times were well understood by experimenter, subject and 
measurer. 
49 .  
7.5 Frequencies of Tested Current  
A Techtronics 422 oscilliscope was used to reproduce the currents 
produced in this trial by the Medtronics SELECTRA. 
1. 	For group one, dual channel parallel currents of spike wave shape 
(fixed width 80 microsecs) at 80 Hz. (FIG. 7B) Oscilloscope 
parameters were 20 V vertical divisions, 20 millisecs horizontal 
divisions. 
Icm 
Scale: lcm = 0.012 sec 
FIG. 7B High Rate TENS (80 Hz) used in this experiment 
2. For group two, dual channel parallel currents of spike wave shape 
fixed and applied as for group 1 were set at Burst Mode current 
generated at 3 Hz, comprising trains of 7 pulses of internal 
frequency of 80Hz (FIG. 7C). The oscilloscope was set at 5 V 
vertical divisions / 20 millisecs horizontal divisions. 
Icm 
Scale: lcm = 0.012 sec 
FIG. 7C 	Burst Mode TENS (3 Hz) used in this experiment 
3. For group three, the placebo application was exactly the same as 
for the active TENS application (FIG. 7D). The subject did not 
experience any current flow. This was achieved by using dummy 
(inactive) leads supplied by Imbros Pty. Ltd., Hobart, on an 
active TENS machine. No current flow was seen on the 
oscilloscope. 
fn. lb 
Ne current flow from placebo 
/eacts: 
Scale: I in 4 
50. 
7.6 Position for Experiment 
The patient was supine with a rolled towel to support the painful 
knee 15 degrees from full extension (FIG. 7E). This position was 
proposed because: 
1. the joint is not at extreme flexion or extension, 
2. the vastus medialis, hamstrings and qastrocnemius are rendered 
inactive and therefore have no immediate bearing on joint pain 
[Hollinshead (1979), McConnell (1986)], 
3. the joint capsule is not stressed (Levine 1979) , and 
4. it permits no 'rocking' of the knee, and no internal rotation of 
femur on tibia (Brunnstrom 1979). This would not place stress on 
the vascular, ligamentous, cartilagenous or neural structures of 
the knee. 
FIG. 7E Subject in the position for the experiment 
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52. 
7.8 Electrode Placement  
In all tests, the four electrodes were placed on acupuncture points 
Spleen 9, Spleen 10, Gall Bladder 33 and Urinary Bladder 40. 
The four points are academically described in CHAPTER 5 (Mann 1987). 
FIG. 7G Illustrating the electrode placement at Gall Bladder 33 
FIG. 7H Illustrating the electrode placement at Urinary Bladder 40 
53. 
Scale: I in 2 
FIG. 7j 
MeasurinE the 
knee circumference. 
FIG. 71 Illustrating electrode placements at Spleen 9 & Spleen 10. 
7.9 Outcome Factors  
Measurements of knee circumference, range of knee joint movement, 
immediate pain and stiffness change, and length of pain and stiffness 
relief were made by one blinded independent observer (S.C.). 
7.9.1 Objective measurements  
1. The knee circumference was measured in centimeters (FIG. 7J) 
using the joint line as a guide. Marks were placed on the skin 
along the top of the tape at the pre-test measure as a guide to 
the post-test placement of the tape. Measurements of 
circumference were taken to the nearest 0.5 cm. The same tape 
measure was used for each test. 
2. The comfortable Range of Movement was measured in degrees (FIG. 
7K) before and after the test to the nearest degree. The same 
goniometer was used for all the tests. The femur and tibia were 
used as a guide for the arms of the goniometer. 
54. 
FIG. 7K Measuring the range of movement in this study. 
7.9.2 Subjective Measurements  
1.. The change in pain state was indicated by the difference 
between pre-test and post-test Absolute Visual Analogue Scale 
measurements: ie the pain level was measured in centimeters, 
with an error of one decimal place (illustrated in APPENDIX 2). 
2. The change in stiffness state was indicated by the change in 
Absolute Visual Analogue Scale readings as for pain. 
3. The length of time the subject maintained his post-test pain 
and stiffness levels was reported in hours. It was found in all 
cases that subjects could be accurate as to times when their 
"normal" pain and stiffness levels returned. These measurements 
were taken to the nearest half hour of the return of normal pain. 
7.9.3 The outcome factor measured whether strong Burst Mode TENS 
produced significantly greater sympomatic changes in painful 
osteoarthritic knees than did High rate TENS or the placebo. 
7.10 Iknalysis of Data  
The statistical analyses for this experiment were computed by Mr. 
K. Rayner, University of Tasmania Medical School, on SPSS - X 
Release 2.1 + Prime (SPSS User's Guide 1986). 
Changes in pain levels, stiffness levels, circumference and range 
of movement as well as reports of pain and stiffness relief, were 
used to calculate any significant symptomatic change as a result of 
the TENS application. Means, standard deviation and pooled variance 
t-tests were calculated to indicate signifiance. 
55. 
7.11 Possible Confounding Factors Which Were Controlled. 
1. The time of day was a possible confounder. Pain appreciation 
changes diurnally, and the individual pain threshold becomes 
lower as the day progresses. All tests took place between 12 noon 
and 5 pm, to minimise any variation in pain appreciation. It was 
felt that all subjects would have been weightbearing for several 
hours by the test time, and this would have increased any 
mechanically created pain. 
2. The season of the year also was a possible confounder with 
respect to pain threshold. Pain levels are greater in winter, so 
the tests were arranged to take place in July and August 1988, 
winter months in Hobart, Tasmania. The average temperature in 
Hobart during July 1988 was max. 13.7 degrees C.) ay. temp. 
min. 6.1 degrees C.) 9.9 C. 
and the average for August 1988 was 
max. 14.0 degrees C.) ay. temp. 
min. 6.1 degrees C.) 10.05^C. 
(Hobart Weather Bureau Monthly Report, July/ August 1988). 
3. Sex bias which may have confounded results was addressed by 
randomly distributing the subjects. It was interesting to note 
that the suggested ratio of male and female subjects found in the 
literature was also found in this study. 
4. The difference between acute and chronic pain of osteoarthritis 
was addressed by ensuring that all subjects had suffered from 
osteoarthritis of the knee for longer than 6 months. 
5. Medication, a possible confounder of pain appreciation, was 
withheld prior to the test. The withdrawl of each of the 
possible types of medication was in accordance with the maximum 
half-life of the drugs within each class (Shane & Grant 1987). 
Medication was not restarted until 24 hours post-test. 
APPENDIX 3 illustates the half lives of all the arthritis drugs 
used by subjects in this trial. 
6. Previous experience with TENS was eliminated as a confounder in 
the pre-test inclusion factors. Any subject who had experienced 
TENS current previously was not admitted to the trial. 
7. Inability to use AVAS was considered an issue. However, no subjec 
had dificulty in using the AVAS in this study. 
8. The blinded, independent measurer (S.C., a typist) was taught by 
K.A.G. to take the test measurements. Her skills were assessed 
by another physiotherapist, (J.C.), who was uninvolved with the 
trial, prior to any testing taking place. The line of the femur 
and tibia were taken as guides for placement of the goniometer 
arms, and ink marks were made at the top of the tapemeasure to 
facilitate remeasuring. The results were not communicated to 
the subject during or after the test and the measurer was unaware 
of which frequency was being administered to which group. This 
measurer (S.C.) also collected the times of return of "normal" 
pain and stiffness at 24 hours after the test. 
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7.12 Possible Confounding Factors Which Were Unable to be Controlled. 
1. Age of the subject was a possible confounder. Although it may have 
been partly addressed by randomization, it was not possible to 
distribute age evenly in each group (Refer to section 8.9.1). The 
age of the subject may have altered his/her pain threshold and his 
expectation of the pain cycle. The age of the subject may have 
affected his exercise level and his diet as well. 
2. The length of time the subject suffered from osteoarthritis was 
considered to be a possible confounder. The histograms seen in 
section 8.9.2 show that length of time of osteoarthritis diagnosis 
was unevenly distributed within each group. The length of time of 
diagnosis may have altered pain perception, pain expectation, 
limitations placed on the knee by the individual, and the 
expectation of a result. 
3. Diet and exercise were possible confounders, when considering 
levels of Vit B3, necessary in daily food intake for Serotonin 
production. No effort was made to question subjects for their 
eating habits, as the experiment was not addressing diet or 
exercise in arthritic pain. However, to assess diet in relation to 
the subject's performance with TENS could be an area for future 
study. 
4. Subjects were instructed to pursue their normal exercise habits 
after the test, as it was felt that "checking joint performance" 
may have occurred if some pain relief was the result of a TENS 
application (Mannheimer & Lampe 1984). It was not possible to 
enforce this, however, and undue exercise may have confounded the 
results. 
7.13 Experimental Protocol 
Send all participating subjects an information sheet some days 
prior to the test outlining the testing procedure (APPENDIX 1). At 
the test check that each subject understands the testing procedure, 
that he/she knows what is required and still agrees to participate. 
1. Check that the subject tallies with the test sheet. Take remaining 
particulars of each subject while he/she is undressing. Take care 
not to imply that any relief of osteoarthritic sympoms will ensue. 
2. While the subject is still standing, tell him, "This scale 
represents pain" (See APPENDIX 2). Ask the patient, "Will you 
mark on it the amount of pain you have in your knee at this 
moment? Notice one end of the scale corresponds to no pain, and 
the other end to pain as bad as it can possibly be". 
3. Repeat this procedure using the stiffness scale on APPENDIX 2. 
4. Position the subject lying comfortably and warmly with a support 
under the knee to rest it in 15 degrees flexion (See FIG. 7E). 
5. Measure the knee circumference (FIG. 7J). Place a mark on either 
side of the knee at the top of the tape as a guide to later 
measure. 
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6. Measure the range of movement of the knee in full comfortable 
flexion and full extension (FIG. 7K). 
7. Set the active TENS (Group 1 & 2) to the required pulse rate, 
checking that pulse shape is correct first. 
8. Check that the placebo TENS leads are not passing any current. 
9. Set the electrodes in place (See FIG. 7G, 7H, 71). 
10a. Explain to the Group 1 subjects that they will feel a 
"tolerable, tingling feeling throughout the area of the knee 
pain". Set the electrodes in place, adjust the intensity until 
the desired sensation is experienced. Ask the subject to 
maintain the sensation by increasing the intensity every 5 
minutes by 2-3 mA (FIG. 7F(i,ii)). 
10b. Explain to the Group 2 subjects that they will feel a 
"tolerable, pulsing feeling that will produce visible muscle 
contractions". Continue as for Group 1, and ask the subject to 
increase the intensity as for 10a. to maintain the sensation if 
required. 
10c. Explain to the Group 3 subjects that they may not feel anything, 
as a very high frequency current, which the skin may not 
appreciate, is being tested for its ability to relieve pain. 
This instruction will be visually reinforced by the digital 
display on the unit. Ask these subjects to increase the 
intensity every five minutes throughout the test, by 2-3 mA, (as 
for 10a). 
11. At the end of the test period, measure the knee circumference 
using the marks as tape guides. Also measure the range of 
movement in both full comfortable flexion and extension. 
12. When this is completed, ask the patient to stand up and move 
around before marking his pain and stiffness levels on the visual 
analogue scales. Indicate on the scale which of the marks were 
pretest and which were post test. 
13. Arrange to contact the subject in 24 hours, for the report of the 
times (if) when "normal" pain and stiffness returned. The subject 
must be reminded to continue with his normal activities over the 
next 24 hours, and not to abnormally rest or stress the knee. 
14. Thank the subject for participating in this trial. 
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RESULTS  
Abbreviations: AVAS - Absolute Visual Analogue Scale 
cm 	- measured in centimeters 
diff - difference between before and after test AVAS 
result measured in centimeters 
X 	- mean 
SD - Standard deviation 
SE - Standard Error 
B/T - Before Test 
A/T - After Test 
Group 1 - High Rate TENS 
Group 2 - Burst Mode TENS 
Group 3 - Placebo 
Years O.A. - Length of time subject suffered from 
osteoarthritis. 
TABLE 8.1 Particulars of subjects participating in the trial. 
: Males 	Females 	Age 	: Years O.A. 
: SD 	:SE 
_ 
X SD SE 
:Group 1 7 13 65.6: 16.2: 3.6 : 5.6 6.6 1.5 
:Group 2 8 12 65.7: 16.5: 3.7 : 9.9 10.5 2.3 
:Group 3 8 12 68.4: 11.3: 2.5 : 7.9 9.0 2.0 
:Total 23 37 66.5: 14.6: 1.89 : 7.8 8.9 I 1.1 
60 
When computing the results for this trial, the non-significance 
of the F-Value indicated that the t value and its significance be read 
from the Pooled Variance Estimate rather than the Separate Variance 
Estimate. This was an indication of the homogeneity of the three 
groups within the study sample. 
TABLE 8.2.1 
Calculated 
I 	r I I L  
1 t I 	I  
I 
!Group 1 	i 
IGroup 2 	1 
!Group 3 1 
, L  
PAIN MEASUREMENT : Absolute Visual Analogue Scale in cm. 
1 from Data Sheet; App. 	2) 
in pain relief, 	not average diff. 
71- 'Pain relief (cm B/T - cm A/T) 
h 	_ T 	1 
	
SE' X 	1 	SD 	1 	SE 
T 	1 I 0.6 1 	4.97 1 	3.31 	0.74 
0.4 	' 	4•43 1 	1.81 	0.40 
0.661 	3.26 1 	2.8 	0.62 
1. 1 L..--1 
(AVAS 
on INDIVIDUAL DIFFERENCES 
1 Before/Test 	1 After/Test 
- -1 	/ 	-1r 1 X 	SD 	I 	SE 	I 	5-C 	I 	SD 	I 1 
1 	-I -I I- 4 7.11 	3.0 	10.66 	I 	2.2 	!2.8 	I 
5.9i 	2.3 	10.51 	I 	1.5 	:1.8 	I 
6.31 	2.4 	10.52 	I 	3.48:2.9 	I 
 
-I 	...1 . 
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TABLE 8.2.2 	Tests of significance (Pain Measurement) 
ii) Internal t Values (Comparing pain relief Before/Test with 	1  
1 	 Pain Relief After/Test) 19 df. 
10.05 sig. level on 2 tails; Critical t value: t = 2.093 
1 t value 	I 	2-tail prob. 
1Within Group 1 
'Within Group 2 
rithin Group 3 
1 6.66 
11.00 
5.25 
4 
0.000 
0.000 
0.000 
All TENS applications produce significant pain relief when comparing 
the before Test measurement with the after Test measurement within 
each group. 
	1
I 
I 
1 1 
1  
ji- 
15.8 
17.7 
10.2 
7. 
I 
I 
 1  
--t 
SD! 
9.9 1 1 8.0 
10.2' 
' I 
SE! 
2.2 
1.8 
2.3 
/ 
1 
I 
1 
4 
Iii) Comparing Pain Relief between groups: 38 df 
10.05 sig. level on 2 tails: Critical t value: t = 2.021 
10.05 sig. level on 2 tails; Critical F value: F 	="2.51 
7 / 
I 
F Value 	2-tail 1 t Value (Pooled Varianc I prob. 	I Estimate) t 	 4  IGroup 1 	 I 1 1 + 	3.43 	1 0.01 	0.64 
'Group 2. I I 1  
:Group 1 1 	1 
+ 	1.41 	1 0.46 	1.56 
'Group 3. I I 
1.32 
1 
2-tail 1 
prob. 
1 
0.52 
1 0.12 
0.19 
--1 	-r 
,Group 2 1 
1 	+ 2.43 	1 0.06 1 'Group 3. 
There is no significant difference between the Burst Mode TENS, High 
Rate TENS and placebo TENS pain reducing ability. 
TABLE 8.3.1 LENGTH OF PAIN RELIEF (Hours) 
F 
1 
F group 1 
group 2 
Group 3 
L 
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TABLE 8.3.2 Test of Significance (Length of Pain Relief) with 38 df 
1 0.05 sig. level on 2 tails; Critical T value: t = 2.021 	1 
10.05 sig. level on 2 tails; Critical F value: F 	=" 2.51 
9 1 F value 	2-tail 	t value (pooled variance' 2-tail 
1 	 prob estimate) 	prob. 1 1 	  
1 oup Gr 	1 1 I 
I 	+ 	1 	1.53 
I 	0.36 
	
I -0.65 	I 0.52 I Group 2 1 I _I  
-I - 	 Gr 1 -I 1 	1 	1 oup 	 1 1 
1 	+ 1.06 1 	0.90 	1.77 	1 0.085 
1Group 3  
1 	-1 	1 	-I 1 	-I 'Group 2 1 1 : 	+ 1.62 I 	0.30 	2.58 	1 0.014 
IGroup 3 1 I 1 , 	J J . ,  
Burst Mode TENS only produced a significant length of pain relief when 
compared with the placebo. 
TABLE 8.4.1 STIFFNESS MEASUREMENT : Absolute Visual Analogue Scale 
(AVAS2 in Appendix 2) (cm) 
Calculated on INDIVIDUAL DIFFERENCES in Stiffness relief, not average. 
r 1 1 --, 1 
i 1 Before/ Test 	1 After/Test 
;
Stiffness Relief (B/T - A/T) 
1-- 	-1 = 1 	7 	1 	1 	1 	1 -1 1 1 I X 1 SDI SE 	A 1 SDI SE 	1 	x 	1 	SD 1 	SE 
I- 1 	-1 	1 	4 -, -1 	1 J  1 13r o up 1 	6.0 t 3.9 . 0.8 1 1.6 1 2.61 	0.59 1 	4.4' 	3.8 	0.85 
proup 2 1 5.7 1 3.6 ' 0.8 	2.1 1 2.8 , 0.64 t 	3.5 ' 	3.3 ' 	0.74 1 	1 ,Group 3 I 4.6 1 3.8 1 	0.86 	2.4 1 3.1 1 	0.69' 	2.2 : 	2.3 ' 	0.51 L 	..., 	__1 	- I J 	e I _1 j ot 
TABLE 8.4.2 Tests of Significance (Stiffness Measurement) 
1 Internal t Value (19 df) (Comparing Before/Test with After/Test) 
10.05 sig. level on 2 tails; Critical t value: t = 2.093 
'within Group 1 
'within Group 2 
1 1ithin Group 3 
7 
1 	t Value 
5.17 
4.76 
4.32 
2-tail prob. 
0.000 
0.000 
0.000 
1 
There is significant stiffness relief occuring in each of the TENS 
applications. 
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ii) Between Groups; Comparing Stiffness Relief between groups (38df) 
1 10.05 sig. level on 2 tails: Critical t value: t = 2.021 
	1 
10.05 sig. level on 2 tails: Critical F value: F 	=- 2.51 
1 	1 	 7 1 
t I 	F value 2-tail 	t Value (Pooled Variance l 	2-tail 
I prob. Estimate) 	prob. 1 I  1 -I 	 4 	 1 (Group 1 	1 
1 	+ 	I 	1.3 	0.56 	0.75 	 0.45 	1 
'Group 2. 	1 1 J 
Group  1 
+ 	2.8 	0.03 	2.22 
Group 3. 
(Group 2 	1 
+ 	1 	2.15 	0.104 	1.50 
'Group 3. 
The only significant difference in stiffness relief is between High 
Rate TENS and the Placebo. 
TABLE 8.5.1 	LENGTH OF STIFFNESS RELIEF (Hours) 
1 11 SD 	SE 1 
	
1 	Proup 1 
(Group 2 
Group 3 	 1 
TABLE 8.5.2 Tests of Significance (Length of Stiffness Relief) (38df) 
10.05 sig. level on 2 tails; Critical t value: t = 2.021 
	1 
0.05 sig. level on 2 tails; Critical F value: F 	=- 2.51 
1 	 1 
0.03 
0.142 
16.35 10.6 2.38 1 
15.95 9.1 I 2.041 
7.05 9.2 2.041 
F value l 2-tail 
prob. 
1 
1 
t value (Pooled Variance 
estimate) 
2-tail 
prob. 
1.37 I 0.50 0.13 I 0.89 
 	-I 1 
1.35 0.51 2.96 0.005 
1 1 -1 1 
1.01 0.98 3.08 0.004 
1 
1 !Group 1 	1 1 	+ 1 IGroup 2 	1 
I 	I 'Group 1 
+ 	I 
'Group 3 	I 
I 	1 
'Group 2 	1 
I 	+ 1 
Group 3 L. 	 
There is a significant difference between the length of stiffness 
relief produced by Burst Mode TENS and the placebo, and between High 
Rate TENS and the placebo. 
'Group 
!Group 
laroup 
TABLE 
F 	X 1 
1 	: 39.3 
2 ; 40.6 
3 	39.8 1 
8.7.2 
7F i !Before /Test 	rAfter/ Test i 1 [Circumference Change 	, 
Tests of Significance; Between Groups (38df) 
r 1 _ 1 t 
 
1 1 F SD ! SE ' 	X 	1 SD 1 SE 1 	X 1: 	SD k 	SE 
1 
L + 	-1 L 	4 r r 1 1 3.1 	10.7 1 38.9 ; 3.2 1 0.72 1 	0.37 I 	0.35 1 	0.08 1 
1 4.5 	'1.0 1 39.8, 4.5 1 1.02 1 	0.77 1 	0.75 ; 	0.16 ] 
13.3 	'0.741 39.4 1 3.2 1 0.72 1 	0.40 1 	0.44 1 	0.10 t i 
	
L. 	L 	" 	A. 	P 	
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TABLE 8.6 Tests of Significance Between Length of Pain Relief and 
Length of Stiffness Relief in Each Group. (19df) 
1 	 1 10.05 sig. level on 2 tails; Critical t value: t = 2.093 	1 
1 1- 	T 	r 	7- 	1 T 1 
1 1 A Diffi SD !SE 	Corre1- 1 2 tail t Value 	2 tail prob, 1 1 	1 1 	lations ; prob. 	 1 1 1  1 r 1 	 -t1Group 1 1 -0.54 	110.7 1 2.4 1 0.46 	! 	0.04 1 	-0.22 	0.82 1 !Group 2 1 1.72 	1 8.8 11.971 0.47 	' 	0.03 1 	0.87 0.39 
!Group 3 1 3.1 	1 8.9 L1.9 I 0.57 	1 	0.01 1 	1.56 	0.13 1 J J 	_ _1 	I 
!There is no significant difference between lengths of pain relief and 
!lengths of stiffness relief. 
6 	
TABLE 8.7.1 CIRCUMFERENCE MEASUREMENT (cms) 
Calculated on INDIVIDUAL DIFFERENCES, not average difference. 
-1 0.05 sig. level on 2 tails; Critical t value: t = 2.021 
1 	
• 10.05 sig. level on 2 tails; Critical F value; F -= 2.51 	1 
I 	
i r 	  -I F Value 2 tailed 	t Value (Pooled Variance r 2 tail 1 
Prob. Estimate) 	1 1 prob. 1 
1 
-1 1- 
1 Group 1 	 1 
1 + 4.41 	1 0.002 	-2.15 	1 0.04 !Group 2 I 	1 	I 1  
I 	I- 11- t I-Group 1 1 	1 1 + P 	1.56 	, 0.34 	-0.20 	1 0.84 
Group 3 1 1 
1- 	 T Group 2 1 1+ 2.83 	0.03 	I 	1.92 0.06 1 1 roup 3 _1 L 	L t 	_I 
Burst Mode TENS produced a significantly greater change in 
circumference than High Rate TENS. It may have also produced greater 
change in circumference than the placebo, but this did not reach 
statistical significance. 
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TABLE 8.8.1 	CHANGE IN RANGE OF MOVEMENT (degrees) 
Calculated on INDIVIDUAL DIFFERENCES, not average difference. 
1 	I Before/ Test 	I 1 1 After / Test 	Change in R.O.M.  I i 	 4 
I I - 1 1 
.,.._. r - 	T 
 
_I  
X 	1 SD 	1 SE I X 	1 SD 1 	SE I 	k r 	SD 1 	SE1 I I  ( 	I 	I 	1 	I 	I- 	1- 	1 I -t proup 1 .103.4. 10.2, 2.65 1 110.3,9.6 1 2.72 1 6.9 	7.9 	1 	1.77 
Group 2 ' 97.8' 	9.2 	1.76.108.0 1 9.3 1 2.54 110.2 	I 12.9 	1 	2.88 I tGroup 3 1 105.91 	9.7: 1.45'108.9 1 7.4 1 1.97 1 2.9 6.4 I 	I 	j 1 	4 I 	' 	I 
	
_t 	1.43J 
TABLE 8.8.2 Tests of Significance: Between Groups (38 df) 
l 1 0.05 sig. level on 2 tails; Critical t value: t 	= 2.021 
1 1 	  0.0.5 sig. level on 2 tails; Critical F value: F 	=- 2.51 	1 
1 1 	 i 	 1 F Value T  2 tailed 	t Value (Pooled Variance -I  2 tail 
prob. 	I Estimate) 1 I 	i 
I I j 
prob. 
!Group 1 I 	I 	I 1 
I 	+ 	I 	2.64 	I 	0.04 	I -0.96 	I 	0.34 	I !Group 2 I 1 1 1  
I 	7 I ' Gr o up 1 I I 	4. 	1.52 	1 	0.36 	I 1.73 0.093 	I IGroup 3 I 	fr I I t  1 i 	_I  1 	T Group 2 1 1 1 1 I + 	1 	4.02 	1 	0.004 	1 	2.23 0.03 	I I 
Burst Mode TENS produced a significantly greater change in Range of 
Movement than High Rate or the Placebo. 
Gr o up 3 I 
	 J. 
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FIG. 8B Age Histogram for Group 1 (High Rate TENS). 
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FIG. 8C Age Histogram Group 2 (Burst Mode TENS) 
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FIG. 8D Age Histogram Group 3 (Placebo Group). 
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FIG. 8E 	Length of O.A. Histogram 	(Entire Study Sample) 
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FIG. 8F Length of O.A. Histogram Group 1 (High Rate TENS) 
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FIG. 8H. Length of O.A. Histograms Group 3 (Placebo Group) 
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DISCUSSION  
9.1 Key Findings  
9.1.1 In this study, strong Burst Mode TENS has been shown to produce 
significantly greater effects when compared with High Rate TENS, only 
on the following measurement: 
the immediate post-test change in circumference measurement. 
The results from this study do not support the hypothesis that 
strong Burst Mode TENS produces significantly greater change in pain, 
stiffness, and range of movement than that produced by High Rate TENS, 
when both are tested on painful osteoarthritic knees. One would be 
uncomfortable with failing to reject the null hypothesis. 
9.1.2 In this study, strong Burst Mode TENS did not produce 
significantly greater effects than High Rate TENS on the following 
measurements: 
1. the immediate pain relief felt after the TENS test, 
2. the post-test length of pain relief, 
3. the immediate stiffness relief felt after the TENS test, 
4. the length of stiffness relief after the TENS test, and 
5. the immediate change in range of movement measurement. 
9.2 Comparing the Study Results with the Author's Expectations. 
Given the results of this study, discussion must continue about the 
presently accepted actions of High Rate, strong Burst Mode (Low Rate) 
and placebo Transcutaneous Electrical Nerve Stimulation with respect 
to painful osteoarthritis of the knee. 
From the literature and clinical observation, this author expected 
that strong Burst mode TENS would produce effects significantly 
greater than those produced by High Rate TENS or the placebo, in all 
measurements taken in this study. On the available double blind data 
for TENS applied to osteoarthritic knees, strong Burst Mode TENS was 
expected to reproduce the Low Rate TENS effect, by producing 1.5 - 2 
times the length of pain relief produced by High Rate TENS, but 
neither creating more than 6 hours pain relief. 
From this study, the major notable issues which invite comment were 
1. that Strong Burst Mode TENS did not produce significantly greater 
symptomatic changes than High Rate TENS, except on joint 
circumference. 
2. the High Rate TENS effect on immediate osteoarthritic stiffness, 
2. the size of the placebo response, and 
3. the lengths of pain and stiffness relief produced by both High 
and Burst Mode TENS. 
The results from this study indicate areas of research into TENS 
action that have not yet been fully explained in the literature. For 
adequate discussion to occur, the hypothesis must be considered in 
each of its components. 
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9.2.1 The Immediate Pain Relieving Effects of TENS  
There was no significant difference when comparing the strong Burst 
Mode, High Rate and placebo effect on decreasing immediate pain, 
measured by the Absolute Visual Analogue Scale. It would appear that 
both active TENS applications had no greater effect on chronic 
osteoarthritic pain than the placebo. Both High Rate and Burst Mode 
TENS relieved the average pre-test pain by more than 50%, (20% and 30% 
respectively, greater than the placebo), suggesting that both TENS 
applications had been successful [Salar et al (1981), Hansson & Ekblom 
(1983)]. The placebo TENS relieved the mean pre-test pain by 45%. It 
could be argued that with a larger study sample, High Rate and strong 
Burst Mode results may approach more significant levels. 	Randomly 
assigning the subjects into the groups was expected to adequately 
distribute important differences in both pre-test and post-test pain 
appreciation. 
9.2.2 The Length of Pain Relief After the TENS test. 
Only strong burst mode TENS produced a significant length of pain 
relief when compared with the placebo. However, the low frequency TENS 
result was not significant when compared with the High Rate TENS 
result, and it could be argued that greater numbers of subjects may 
have created a significant High Rate response. So different were both 
the active TENS results to those suggested in the literature, that 
this author felt that it indicated further discussion. 
Both the High Rate TENS mean (15.8 hours) and the Burst Mode TENS 
mean (17.6 hours), from this intervention, are in excess of those 
suggested in the literature on TENS for osteoarthritic knees. Double 
blind studies by Mannheimer & Lampe (1984), Smith et al (1983), 
Taylor et al (1981), and Thurin et al (1980) indicate that High Rate 
TENS pain relief will last 1 - 3 hours, with Low frequency TENS pain 
relief lasting up to 6 hours after stimulation ceases. 
One of the factors determining subject selection in this experiment 
was that all subjects suffered from present, chronic pain in their 
knees. It has been shown that chronic pain sufferers have lower than 
normal levels of CSF and blood stream intrinsic opiates by virtue of 
their constant pain [Sjolund, Eriksson & Terenius (1977), Terenius & 
Wahlstrom (1975), Terenius (1979)]. Chronic pain patients could be 
expected to have different autonomic function and behaviour patterns 
from experimental pain subjects. It must be noted that Von Knorring et 
al (1978) indicated that the expectation of pain relief was directly 
related to the length of time the subject had suffered from chronic 
pain. Not only was this study sample affected by the withdrawl of the 
usual medication, but all tests took place on a winter afternoon when 
endorphin levels could be expected to be at their lowest. All 
subjects were ambulating before the TENS test, and mechanical and 
neural osteoarthritic pain mechanisms would have been established by 
the test time. 
9.2.2.1 High Rate TENS Action on Length of Pain Relief. 
Pain relief from High Rate TENS is expected while the larger, fast 
acting afferent fibres are being stimulated sufficiently to override 
the pain fibres, while the pattern of pain recognition may be re-
established up to 1 hour after disruption by TENS. A tolerable 
intensity is considered necessary for effective stimulation. 
Although Merskey (1974) indicated the enormous higher cortical input 
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of personality, expectation and conditioning in pain appreciation, one 
could reasonably expect that the mechanical pain of an osteoarthritic 
knee would recommence immediately weightbearing was resumed. 
Earlier experiments reporting the use of High Rate TENS as a pain 
relieving agent may not have been conducted over a sufficient length 
of time at sufficient stimulation intensity using the most effective 
electrode sites, to establish pain relief by any mechanism other than 
segmental &/or pattern disturbing action. Experiments such as those 
by Burton & Maurer (1974), Melzack (1975), Thorsteinsson et al (1977, 
1978) were conducted over less than 20 minutes on spinal segments 
and/or nerve roots. Because the immediacy of High Rate TENS action may 
have been evident, the full possibilities of its action may not have 
been considered. The experiments conducted by Mannheimer & Lampe 
(1984), Dougherty (1979), Thurin et al (1980) and Taylor et al (1981) 
were over longer periods (25 - 30) minutes, at comfortable intensity, 
over cutaneous nerves, trigger points, and acupuncture points. These 
studies reported significant pain relief lasting after the treatment 
period but not in the order of the results of this study. The 
tolerable intensity, used in this study, was probably higher than that 
used previously, and may have contributed to the longer pain relief. 
9.2.2.2 Burst Mode TENS Action on Length of Pain Relief. 
It was expected that Burst Mode TENS would produce longer pain 
relief than High Rate TENS. This was because of the known endorphin 
action occurring after 30 minutes stimulation of strong intensity 
sufficient to create muscle contraction. Although the onset of pain 
relief with this stimulation frequency is slow, the effect is gradual 
and peaks after 30 minutes steady stimulation (Andersson & Holmgren 
1976). It was anticipated in this experiment that the length of pain 
relief could be maximised by placing the electrodes over acupuncture 
points and maintaining a just tolerable intensity which created strong 
rhythmic muscle contractions. However, the length of pain relief 
exceeded expectation, although it was not in the ratio predicted by 
the literature when compared to the High Rate TENS result. 
Tseng et al (1976) suggest that B-endorphin may take up to 10 hours 
to be enzyme degraded after stimulation ceases. Hormones such as 
Adrenocortcotrophin and B-lipotropin are released by the brainstem 
centres, along with intrinsic opiates, as a result of stress. These 
substances may increase an initial endomorphin response, but as their 
half lives are shorter than endomorphins, they may have a decreasing 
effect over time (Wilkes et al 1980). Thus it may be that the stress 
of attending an appointment, the withdrawl of medication and 
subsequent increase in pain, and having to focus on the behaviour of a 
chronically painful knee may have precipitated the release of 
additional pain mediating agents. 
Although very little is written, it seems possible that Burst Mode 
TENS may also have some affect on the Pain Gate system, either by a 
fatigue mechanism over time, the effect of the train of high frequency 
pulses, or by chemical agencies via a negative feedback loop. As Low 
frequency TENS is known to progressively elevate pain threshold, its 
effect on disrupting neural pattern mechanisms, altering higher brain 
pain appreciation through memory, and altering physical movement 
expectation must be considered. Tests comparing the effects of pure 
Low Rate TENS and Burst Mode TENS are indicated to clarify any 
possible differences in action that have not been noted to date. 
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9.2.2.3 Placebo TENS Result 
The effect of placebo TENS on chronic pain is reported by 
Thorsteinsson et al (1977) as 3396. Assuming this is based on the mean 
pain relief, in this study the effect is 4096. 
The reaons for this response may be a combination of factors: 
1. the application of TENS to incurable chronically painful knees 
may have created an expectation in excess of the actual effect of 
the current. 
2. being invited to participate in a trial of this nature may have 
created an expectation. 
3. the placebo effect created by this experiment may have been 
enhanced by the use of the visual display on the Selectra TENS 
used for the experiment. 
4. the design of the experiment - in which the subjects were 
encouraged to increase the intensity of the TENS every few 
minutes - may have mediated a pain reducing effect by giving the 
subject active control over his own pain relief. 
5. the subject's age and the length of time he had suffered from 
osteoarthritis may have affected the result. 
9.2.2.4 Factors that may have influenced both High Rate and Burst 
Mode TENS Pain Relief 
1. Combinations of some of the controlling factors in this 
experiment may have augmented the experimental results. The 
factors which may have influenced the results are thought to be: 
i. the 30 minute experimental length, 
ii. the tolerable, constant stimulation intensity, 
iii. placing electrodes over positions which were common to 
acupuncture points, common painful spots, trigger points and 
cutaneous nerves around the knee, 
iv. the experimental design, where each subject was encouraged to 
increase the intensity to maintain the TENS sensation. 
2. Other factors which may have influenced the result may be: 
v. the effect of the muscle contraction, blood flow alteration 
and increased joint lubrication due to the electrical 
stimulation. 
vi. error in subject reporting of pain relief. 
vii. that factors which possibly enhanced the placebo effect may 
have also enhanced the reporting of true pain relief. 
9.2.3 Immediate Post-Test Stiffness Relief  
The only TENS application to have any significant effect at the 
0.05 level was High Rate when compared with the placebo. It could be 
argued, that with greater numbers, the Burst mode TENS result may have 
been significant. This author's experience as a clinical 
physiotherapist has shown that stiffness is a real and definitive 
problem to many chronic osteoarthritic sufferers. It was interesting 
that no subject in this study had any difficulty differentiating 
between stiffness and pain, and in reports of length of pain and 
stiffness relief, the answer was often diffferent. 8 subjects (4 in 
Group 1, 2 in group 2, 2 in group 3) had no problem with stiff knees, 
while 7 subjects had more stiffness than pain. 
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Given the means of the pre-test stiffness measurement, it must be 
suggested that by chance the placebo group was less stiff than either 
active group. The placebo group also had a greater mean pre-test range 
of movement, which would authenticate this suggestion. There is no 
precedent in the literature for measuring the effect of placebo TENS 
on stiffness. However, it must be considered that these factors may 
have affected the placebo response to the stiffness measurement in 
this study. Histograms of pre-test stiffness measured on the Absolute 
Visual Analogue Scale, and the objective pre-test Range of Movement 
are illustrated for each group in APPENDICES 5 and 6. 
A discussion on causal factors of stiffness is relevant in this 
section. Although the concept of stiffness is an abstract one, the 
causal factors are more likely to be objective and mechanical. Muscle 
tone and strength, blood supply, concentration of toxins within the 
joint, joint swelling and ligament dysfunction are all factors which 
could be expected to affect the stiffness of the joint. It was 
interesting to note that there was no correlation on the overall 
Spearman Matrix between pain and stiffness measurement on the 
Absolute Visual Analogue Scale, although there was consistent 
correlation between the stiffness measurements, circumference 
measurements and changes in Range of Movement (See APPENDIX 7). 
Significant stiffness reduction after High Rate TENS poses some 
questions. In its original concept, High Rate TENS affected only the 
spinal gating mechanism, although the possibility of endomorphin 
stimulation has already been discussed. Cognitive influence, 
personality and expectation cannot be expected to play a large part in 
a measurement that is inherently objective. The fact that there is no 
significant overall relationship between pain relief and stiffness 
relief cannot suggest that as pain reduces, so does stiffness. There 
must be biomechanical factors acting on the joint to cause objective 
changes which could lead to a subjective assessment of a decrease in 
stiffness. 
9.2.4 Length of Stiffness Relief Lasting After the Test. 
Both High Rate and Burst Mode TENS created significant lengths of 
stiffness relief when compared with the placebo. Given that the 
experimental methods were identical, this result becomes interesting 
when it has been seen that Burst Mode TENS did not create significant 
changes in stiffness immediately after the TENS test. This author was 
prepared to accept that the endorphin action of Burst Mode TENS, 
possibly creating some local joint change in blood supply and 
lubrication, may not have peaked immediately after the test, thus not 
creating maximum stiffness relief until some time later. It was 
expected, however, that the overall stiffness relief would last longer 
after Burst Mode TENS that after High Rate TENS. This was not the 
case, and barring experimental error, questions as to the action of 
High Rate TENS must be asked. Is there an objective local change in 
joint behaviour after the tolerable intensity High Rate TENS 
application, that is not demonstrated by the Pain Gate Theory, 
cognitive influences, pattern generation, or intrinsic opiate 
production? The use of acupuncture points for electrode placement may 
have stimulated local objective changes hitherto only associated with 
lower frequency currents, although the size of the electrodes would 
have negated a pure acupuncture response. Without biochemical 
measures, these questions can only be hypothetical. However, the 
conventional use of High Rate TENS should perhaps be reassessed. 
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The placebo response in the length of stiffness relief measurement 
in this intervention invites questions. Given that stiffness is not 
directly related to pain change, any endorphin production and changes 
in joint behaviour generated by personality and expectation cannot be 
expected to have lasting effects on a measure such as stiffness. Given 
that the mechanical components of osteoarthritic pain would be re-
established within a short period of recommencing weightbearing, the 
mean length of placebo stiffness relief is higher than could be 
anticipated from an application that should have had only a resting 
effect on joint performance. 
9.2.5 Circumference Change  
Strong Burst Mode TENS was the only TENS application to produce 
significant changes in joint circumference immediately after the test. 
The effect was expected by this author, due to the low frequency 
nature of the current and the already documented objective changes to 
joint performance created by Low Frequency TENS current [Scott 
(1969), Garl & Cooper (1979), Wolf, Gersh & Kutner (1978)]. The change 
in joint circumference could be expected because of: 
1. the strong constant rhythmic muscle contraction, 
2. the pumping action on the pockets of swelling within the joint, 
3. the alteration in blood supply, and 
4. local vascular and synaptic endomorphin action. 
Given the experimental design, it was not possible for the joint 
circumference to be measured any later than immediately post test. Had 
this been done, a trend in TENS action may have become more apparent. 
This author finds it intruiging that although strong Burst Mode TENS 
creates significant circumference change it does not create 
significant immediate stiffness reduction. Although this may have been 
experimental error, it suggests that stiffness may have other causes 
than simply fluid stasis within the joint. 
Because of the supported, comfortable, rested postion of the knee 
during the test, it may have become less swollen simply by not using 
it for the length of the test time. The placebo effect would be 
expected to to be minimal on such an objective measure. 
9.2.6 Change in Range of Movement  
Strong Burst Mode TENS produced a significant change in Range of 
Movement when compared with the placebo, although with greater 
numbers, High Rate TENS may have also produced a significant result. 
The significant change in circumference with Burst Mode TENS supports 
speculation that a change in Range of Movement could be anticipated, 
as a decrease in fluid around the joint could be expected to create 
greater freedom of movement within the joint. The correlations between 
overall stiffness change, change of circumference and the change in 
range of movement supports the theory that stiffness is related more 
to the objective measures than it is to pain. 
Given the significance of the immediate post-test stiffness result 
from High Rate TENS, it is not surprising that it also appears to 
affect immediate change in range of movement. Further testing of High 
Rate TENS action on increasing range of movement could be supported. 
Again, because of the rested position of the painful joint during the 
test, the placebo effect was expected to be minimal. 
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9.3 Biases That May Have Arisen In This Study. 
9.3.1 Sampling Bias. 
The study sample was drawn from a limited population area. Although 
2 subjects lived on the Tasman Peninsula, and one on the East Coast of 
Tasmania, the rest came from the Northern and Eastern Hobart, 
Kingston, and Huon/Channel area. The number of doctors who replied to 
the study proposal limited the study sample. The subjects most 
easily obtained came from the Royal Hobart Hospital and the author's 
local physiotherapy connections. Such a limited population may not 
have yielded a totally representative sample of subjects with 
osteoarthritic knees, that may have been assembled by sampling from a 
wider population frame. (ie all of Tasmania). It was interesting to 
note that despite the limited method and geographical areas of 
sampling, the ratio of women to men was similar to that suggested in 
the literature, and the numbers of men in each group were similar. 
The question of external validity must be addressed. Given the 
confines of this study and the lack of time, medical support, 
financial and clerical assistance, the identification of suficient 
suitable subjects was a daunting task. That they may not be 
representative of the wider population of osteoarthritics is possible. 
However, given the significance of the results obtained in this study, 
and the fact that the ratio of male and female osteoarthritics in this 
test was comparable with that of wider analytical studies, it is 
suggested that further study into the areas addressed in this work may 
be supported in a more widespread fashion. 
9.3.2 Selection Bias. 
All the subjects who fulfilled the study criteria were randomised 
into groups by an unrelated person (typist; JG). Only one potential 
subject was eliminated (by death); another was enrolled in his place. 
As a result of this protocol, it is felt that no selection bias 
occurred. 
9.3.3 Measurement Bias. 
Measurement bias was minimised by the following steps; 
1. One independent measurer (S.C.) took all measurements. This 
measurer was blinded to which TENS frequency was being delivered 
to which subject. She did not appreciate any possible outcomes 
from the study. 
2. Only chronic sufferers from osteoarthritis (6 months or more) 
were tested. This was deemed to be the minimum length of time 
taken before pain becomes chronic (NH + MRC Report 1988). This 
should have standardised the emotional component of pain (Werner 
1980) which may have affected individual pain threshold. 
3. A standard assessment form was used for all tests. 
4. A standard test protocol was administered. 
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5. The same Transcutaneous Electrical Nerve Stimulator, electrodes, 
active and placebo leads, gel, test position, goniometer and 
tapemeasure were used for each test. 
6. All test results were recorded by S.C.; both immediately post 
test and at 24 hours. 
7. The statistical analyses were done by Mr. K. Rayner of the Dept. 
Community Medicine of Tas. Medical School, although the author of 
this study entered the data. Again, given the time and financial 
constraints of this study, this was unavoidable. 
8. The accuracy of the measurer (S.C.) must be questioned. She has 
no clinical background training to take physiotherapeutic 
measurements. However, she was trained by the author (K.A.G.), 
and her skill was assessed prior to, and during the testing 
period by an independent physiotherapist (J.C.) who was 
experienced as a clinical instructor. It was felt that errors 
made by S.C. during the testing process would be standard 
throughout the three groups, thus randomising any possible 
measurement error. 
9. There may have been errors in the subject reporting of lengths of 
pain and stiffness relief after the test. These factors have 
already been discussed in 9.2.2.3. 
9.3.4 Confounding Bias. 
Some measurable biases, which may have confounded this study, were 
eliminated or minimised by controlling the study framework. These 
factors were discussed in CHAPTER 7. Other biases, which may have 
confounded the results, could not be controlled by this author in this 
intervention. 
1. Age may have been a counfounder. The variations in age of subjects 
was large, and the distribution is shown in histograms in 8.9.1. 
2. The length of time the subject suffered from osteoarthritis may 
have biased his attitude to pain and pain relief. However, there 
was no correlation either overall, or in any individual group 
between the pain and stiffness measurements before or after the 
test and the length of time the subject had suffered from 
osteoarthritis. The distributions of this possible confounder are 
illustrated in 8.9.2. 
There was a significant correlation in the Spearman Correlation 
Matrix between age and the length of time the subject had suffered 
from osteoarthritis, both overall and in the Group tested with 
Burst Mode TENS. The groups tested with High Rate TENS and the 
placebo did not have any significant correlation between age and 
length of time of O.A. It must be suggested that this relationship 
may have affected the attitudes of the subjects participating in 
the study. 
3. The author was known to 22 of the 60 candidates. As the author is 
a local Huon physiotherapist with a well known interest in chronic 
pain management, expectations may have been created in those 
subjects who were familiar with the author. However, it was hoped 
that randomly assigning the subjects into the trial would
distribute this expectation across the three groups. 
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4. The personal attention received when participating in this trial 
may have enhanced wellbeing and consequently altered pain 
thresholds. Two phone calls to the subjects prior to the test, a 
followup contact by letter prior to the test, the knowledge that 
the subject's doctor was being contacted, or had suggested them 
for the trial, the test, and the phone call at 24 hours, may have 
enhanced expectation. 
5. An expectation of a result, despite information to the contrary, 
(verbally at the time of initial contact, and in the written Test 
Information Sheet- APPENDIX 1) may have been created in all 
subjects. The disappointment in ongoing pain relief measures 
currently available for chronic osteoarthritis of the knee may 
have engendered expectation. 
6. The amount of rest or exercise done by each subject after the test 
was an uncontrolled feature of this experiment. Each subject was 
asked to continue his/her "normal" daily routine, but as many of 
the subjects had journeyed some distance to participate in this 
test, more exercise than normal may have been created simply by 
attending the test venue. The desire to privately assess a less 
than normally painful and stiff joint cannot be discounted. 
7. Inadequate diet may have confounded the results. 
8. The invitation to be involved with a study of this nature may have 
created the desire to help. A comment heard often during the study 
was "It may not help me, but it may help someone else". This may 
have biased the subjective results. Again, randomisation could be 
expected to evenly distribute this trend. 
9.4 Conclusions 
9.4.1 This experiment indicated that strong Burst Mode TENS does not 
produce uniformly greater symptomatic changes than High Rate TENS or a 
placebo, when both are applied at a tolerable intensity for the same 
lengths of time to acupuncture points on painful osteoarthritic knees. 
9.4.2 Interesting results were produced by strong Burst Mode and High 
Rate TENS with respect to lengths of pain and stiffness relief after 
the TENS test. Further study is indictated to establish: 
1. High Rate TENS effect on immediate joint stiffness. 
2. whether these responses from High and Burst Mode TENS endure past 
24 hours, and 
3. whether they can be reproduced with repeated stimulation over 
time. 
It is suggested that a larger study sample is required for more 
definitive results. 
9.4.3 The placebo response needs further definition with respect to: 
1. biochemical changes created both centrally and locally. 
2. allowing the subject to control and visualise his own pain 
relief. 
3. the suggestive nature of placebo TENS, and whether it endures 
past 24 hours. 
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9.4.4 The protocol of this intervention may have affected the 
results. Further interventions are indicated to test whether this may 
have happened. Future experimentation is needed to investigate: 
1. the efficacy of acupuncture points for electrode placements for 
High Rate TENS, and the practicalities of electrode size to 
produce such effects, 
2. the exact relationship of the effects of strong Burst Mode TENS 
and pure Low Rate TENS on pain and movement of osteoarthritic 
joints, 
3. the lengths of High Rate and Burst Mode TENS applications 
necessary for maximum and ongoing effect, 
4. the effects produced by different stimulation intensities, 
5. whether other TENS frequencies produce different effects, 
6. the efficacy of TENS on other chronic pain conditions. 
9.4.5 A picture of effective clinical application of TENS to chronic 
osteoarthritic joints may be constructed from this intervention. The 
current literature is mostly nonspecific about parameters for treating 
particular conditions (Wolf & Gersh 1985). The legal, ethical and 
social ramifications suggested by Mannheimer & Lampe (1984) and 
Mannheimer (1987), indicate the need for specificity and definition to 
occur quickly in the clinical useage of Transcutaneous Electrical 
Nerve Stimulation. Without this, the physiotherapy profession may find 
itself unable to manage the growing expectations of their clients and 
allied health professionals. Osteoarthritis is an ideal condition to 
investigate, as it is one of the few conditions were TENS alone is 
acceptable to create pain relief. Although Mannheimer (1987) states 
"TENS does not treat anything - it must be used as an adjunct to other 
treatments", the change in pain, stiffness, swelling and movement 
created by TENS to osteoarthritic knees may be sufficient to establish 
improved useage. As other treatments are largely unsuccesful for this 
condition, few ethical questions can be raised with respect to 
experimentation. 
The advantage of home use of TENS set at specific frequencies, 
specific intensities, and applied at particular sites for set lengths 
of time needs to be assessed for its long term benefit, not only as an 
aid to decreasing medication but also to increasing joint function and 
improving quality of life. It is felt that TENS manufacturers, 
doctors, lawyers, osteoarthritis sufferers and physiotherapists would 
benefit from such knowledge, not only for specifying equipment 
requirements, and advancing appropriate TENS applications, but also by 
helping to define the medico-legal implications that widespead 
prescription of Transcutaneous Electrical Nerve Stimulators for pain 
relief have raised. 
APPENDIX 1  
INFORMATION SHEET FOR TEST SUBJECTS  
1. This procedure is completely safe and your doctor has approved 
this test procedure for you. 
2. The machine being used in this test is a low voltage alternating 
current device applied through four electrodes around the knee for 
30 minutes. You may or may not feel a tingling feeling under the 
electrodes. 
3. You may not experience any change in your usual pain or stiffness 
in your knee. 
4. You should not have taken any anti-inflammatory drugs within the 
last 48 hours, and muscle relaxants within the last 12 hours, and 
any painkiller within the last 4 hours. This will be discussed 
with you over the telephone before the test. 
5. To complete the test, you are asked to take a note of your pain 
and stiffness over the next 24 hours. You will be contacted at 24 
hours after the test for your results. Please note when the pain 
and stiffness you have at the end of the test returns to what you 
normally experience. 
6. If you have experienced this type of machine before, please tell 
the experimenter. 
7. If you wish, you can withdraw from this test at any time. 
AUTHORITY and CONSENT FORM (accepted by the Ethics Committee of the 
Royal Hobart Hospital, 8.6.88) 
	 of 	  
acknowledge that I have volunteered to participate in this experiment 
conducted by Miss K.A. Grimmer. I understand that the procedure is 
safe, may or may not provide pain relief and that I am able to 
withdraw from the study At any time. I am happy to comply with the 
conditions of this study. 
Signed 
Witnessed 	  
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APPENDIX 2  
Test  Record Sheet for TENS testing MMedSci 1988 
Date 	 
Name  	Grp 1 / 2 / 3 
Age 	 
Sex  
Telephone No. 	  
Time of Test  
Usual Medication  
Doctor's Name  
• Length of Osteoarthritis Diagnosis 	 
Joint circumference B/T 	cm A/T 	cm 
Passive Range of Movement B/T 	A/T 	 degrees 
Pain as bad as you have 	Stiffness as bad as you have 
ever had it ever had it 
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No pain 	 No stiffness 
Return of "normal" pain 	Return of "normal" stiffness 
Time 	 Time 	 
,lcm = lcm 
APPENDIX 3  
SERUM HALF LIFE FOR DRUGS USED BY SUBJECTS  in this STUDY. 
1. NONSTEROID ANTI-INFLAMMATORY DRUGS used in the management of 
Degenerative Joint Disease (Shane & Grant 1987) 
Salicylates 
Ecotrin (low dose) 
Trisilate 
Arthropan 
Aspirin 
Nonsalicylates 
Voltarin 
Dolobid 
Indocid 
Orudis 
Naprosyn 
Feldene 
Clinoril 
Tolectin 
Brufen 
USUAL DOSE 
325 mg 
975 mg 
655 mg 
870 mg/5m1 
250 mg 
25, 100 mg 
250,500 mg 
75 mg 
50 mg 
500 mg 
10, 20 mg 
200 mg 
400 mg 
400 mg 
HALF LIFE (Hours) 
0.75 - 2 (High dose) 
12 - 26 
12 - 26 
12 - 26 
0.25 
1.1 - 1.8 
8 - 12.5 
6 - 20 
1 - 4 
12 - 15 
35 - 45 
16 - 20 
1 - 6 
2 
2. MUSCLE RELAXANTS used in the management of osteoarthritis 
(Martindale 1982) 
Serepax 	 5 - 12 
Prednisolone 2.5 - 5 
3. ANALGAESICS used by subjects in the test (Martindale 1982) 
Panadeine 
Panadol 
Panamax Co 
Norgesic 
Paracetamol 
Digesic 
2 - 
1.5 - 2 
2 
3 - 14 
1 - 3.5 
4 - 12 
APPENDIX 4 
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RAW DATA FROM STUDY 
Abbreviations: 
AVAS - Absolute Visual Analogue Scale 
cm - measured in centimeters 
Diff - difference between Before and After 
Test AVAS result' measured in centimeters 
TABLE 1 GROUP 1 SUBJECTS (High Rate TENS) 
PAIN DATA  
P.I. - Patient Identity 
BIT - Before Test 
A/T - After Test 
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Test 
Time(pm) 
AVAS 
BIT(cm) 
AVAS 
A/T (cm) 
-------- 
t - 
I Diff A/T pain 
relief (hours) 
.H 3.30 .7.8 1.3 6.5 7 
GB 12.00 9.8 0.0 9.8 24 
IC 4.00 8.8 0.1 8.7 24 
FB 1.00 6.9 5.2 1.7 19 
V 5.00 4.1 3.0 1.1 0 
RB 12.00 10.0 5.9 4.1 24 
ry 5.00 7.4 1.5 5.9 5 
SH 12.30 2.4 1.8 0.6 19 
PS .1-. 
co 
io 3.00 2.2 0.1 3.1 0 
TG 12.00 4.2 0.2 4.0 24 
1W 12.45 10.0 7.4 2.6 2 
GB 1.00 10.0 0.0 10.0 1 
P 1.30 5.6 0.0 5.6 24 
EV 1.45 10.0 9.1 0.9 17 
IM 1.15 10.0 0.0 10.0 3 
SG 12.00 2.3 0.8 1.5 24 
rC 12.30 8.5 4.5 4.0 24 
CR 12.00 9.1 2.3 6.8 24 
rN 3.30 2.5 0.0 2.5 24 
KH 2.30 10.0 0.0 10.0 24 
___  ____________-_-----. 
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TABLE 2 GROUP 1 SUBJECTS  (High Rate TENS) 
STIFFNESS DATA  
nc P1  c ) 	
co 0
 3 P=1  p. 	
0
 c) P4  74 
P
.  
‹
c
 
0
 04  
riA
 0
  
P
4
  P=1 01  p
 	
0
 0
  
p
4
 CO  
(4
 
c
)
  C4
  
 
AVAS (cm) 
BIT 
AVAS (cm) 
A/T 
Diff 
(cm) 
A/T Stiffness 
relief (hours) 
1.3 0.0 1.3 24 
0.0 0.0 0.0 0 
3.2 0.7 2.5 24 
7.0 5.5 1.5 24 
0.0 0.0 0 0 
10.0 1.8 8.2 24 
8.0 0.0 8.0 0 
10.0 1.1 8.9 24 
2.8 1.5 1.3 16 
0.0 0.0 0.0 0 
10.0 9.0 1.0 2 
0.5 0.0 0.5 24 
5.7 0.0 5.7 24 
7.0 6.0 1.0 18 
10.0 5.4 4.6 3 
10.0 0.2 9.8 24 
8.7 1.0 7.7 24 
8.8 0.0 8.8 24 
10.0 0.0 10.0 24 
7.2 0.0 7.2 24 
-2--- 
TABLE 3 GROUP 1 SUBJECTS (High Rate TENS) 
KNEE CIRCUMFERENCE DATA (in Centimeters) 
E-1  a) a)  
11)  11)  
Ul  c) ul 	
0
  0
  0  0
  0  0  U1  U)  ul 0  
C
)
  
0 	
. 	
• 	
• 	
. 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
. 	
• 	
. 	
• 
;•-■ 	
OD  C)  r—  OD  CD  '1  CD  --,  OD  CD  CO CD 	
0) 	
r
-
 u
)
 CO  
r- 
-.  
c
o
 T
p
 0
)
 c
o
 0
)
  
Tr
 ct,  0) 01  cr cr co c
o
 T
r
 0
0
 0
0
 c
o
 0
0
 
. 
Circumference A/T 
----- 
, Circum. Change (cm) 
38.0 0.5 
40.0 0.5 
36.5 0.5 
38.5 0.0 
36.0 0.0 
44.5 0.0 
40 0.0 
41 0.0 
37.5 1.0 
36.0 0.0 
48.5 0.0 
40.0 0.5 
36.5 1.0 
39.0 0.5 
40.5 1.0 
37.0 0.5 
35.0 0.5 
36.0 0.5 
37.5 0.0 
40.5 0.5 
TABLE 4 GROUP 1 SUBJECTS (High Rate TENS) 
RANGE OF MOVEMENT DATA (in degrees) t  >a)  
U) C)  
0
 
0
  
C
D
 
0
  
CD CO  
0
 
0
  
0
 
0
  
Cp C)  
0
 
C
D
  ul C)  u) C)  
:4 	
00 00  r— 
	r— 
	
0
  
a) r- 	
u) (o
 G0  
(0 CO  
,
A
 
B/T Ext. B/T Flex. A/T Ext. A/T Change 
180 75 180 +10 
180 77 180 +3 
180 55 180 +20 
180 55 180 +10 
170 35 170 +5 
165 135 165 +15 
180 53 180 +7 
180 65 180 +13 
180 45 180 0 E 
180 55 180 0 
175 95 175 +10 
180 65 180 +5 
180 55 180 +5 
170 70 170 0 
170 85 170 +30 
180 60 180 0 
180 65 180 0 
180 60 180 0 
180 65 180 0 
180 75 180 +5 
- --- 
TABLE 5 GROUP 2 SUBJECTS (Low Rate TENS) 
RAIN DATA  
P.I. Sex 
- 
Age Years 
0.A. 
'Test 
Time(pm) 
AVAS 
B/T(cm) 
AVAS 
A/T (cm) 
I, Diff 
(cm) 
A/T pain 
relief (hours: 
66 14 3.30 7.4 
.1
4
  
v
t
i
 c) r- T
r
 .4
1
 CO  
0) '1'  
C4 'cr  
0
 C) 	
0
0
 co .1
4
 T
r
 
N
  
c\I
 
N
  
C\J  
N
 
60 10 4.30 5.3 
36 3 12.30 7.8 
46 2 5.00 4.2 
42 2 3.30 3.2 
82 14 3.00 7.1 
66 2 1.00 5.0 
57 0.5 1.30 2.5 
80 30 12.00 7.1 
54 .-.) 5.00 7.3 
68 10 12.00 3.4 
c o 
Lc) 
N
 
77 4 3.00 7.5 
56 20 1.30 4.4 
72 20 1.30 3.4 
88 5 1.00 10.0 
75 5 2.00 8.2 
96 40 1.00 2.8 
49 3.5 1.00 6.4 
88 10.0 1.00 5.6 
56 1.0 1.00 10.0 
--------------' 
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TABLE 6 GROUP 2 SUBJECTS (Low Rate TENS) 
STIFFNESS DATA  
P.1. 
, 
CO 
	
<
E-4  
C
0
•
11
0
 
	 N
  cr) 0)  
N
O
ID
N
c.0
0
-r
0
c
)
0
0
0
 
<
  
act
 e
0
 0
  
0
 C
O
  
t--
 -
4  -
ti  0
  
0
) 0
  
0
 0
  
0
) 0
  
t-- CO
  •D
 0
  
(0
 0
  
	
.--I 	
.--I 	
1--1  
AVAS 
A/T 
Diff 
(cm) 
A/T stiffness 
relief(hours) 
JF 6.2 2.4 14 
EH 0.0 0.4 24 
JB 0.0 10.0 24 
SS 0.0 3.9 18 
TB 4.8 2.6 17 
HG 0.0 1.2 24 
EW 0.0 4.9 10 
LH 0.6 0.3 24 
UW 7.7 2.0 9 
RC 0.0 0.0 0 
JM 0.8 4.7 4 
OF 2.6 2.6 24 
BL 7.7 1.9 20 
KT 0.0 0.0 0 
EL 7.4 0.0 24 
MC 6.5 1.5 8.5 
AB 0.0 10.0 2.5 
JH 3.6 1.4 24 
GJ 2.7 3.7 24 
,CH 0.0 10.0 24 
TABLE 7 GROUP 2 SUBJECTS (Low Rate TENS) 
KNEE CIRCUMFERENCE DATA (in Centimeters) 
P.1. Circumference B/T Circumference A/T 
, 1 1 1 I 
a) 
	
6.
0
 0
 ID
  u
) 0
  
u
l 0
  
u
l 0
  
Ln
 In
  
0
 0
  
0
 
	
if)  
in
 in
  
0
 LO  
. 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
. 	
• 	
• 	
• 	
• 	
• 	
• 	
. 	
• 	
• 	
• 
(
j
 .-4
0
0
0
N
0
0
-,
0
0
0
-
4
0
-
1
0
0
0
-
4  
'-
'  
N
  
..z 
C.) 
, 	
 
JF 41.5 40.5 
EH 42.0 41.5 
JB 38.5 38.0 
SS 35.5 35.5 
TB 39 36.5 
HG 38 38 
EW 37.5 37.0 
LH 46 45 
UW 39.0 38.5 
RC 36.5 36.0 
JM 43.5 43.5 
OF 41.5 40.5 
BL 56.0 56.0 
KT 44.0 42.5 
EL 37.5 37.0 
MC 40.0 39.5 
AB 36.5 37.0 
JH 38.5 . 37.0 
GJ 40.5 39.5 
CH 41.5 39.0 
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TABLE 8 GROUP 2 SUBJECTS (Low Rate TENS) 
RANGE OF MOVFMFNT DATA (in Degrees) 
Ext. B/T Flex A/T 
NCI  z ,13 	
CO  e4 C-  00 0  co CD  up CD  0 CD  c) 	
0  c) al  c> u0  
_z 	
--I  CA  0 	
-• 
o
 +
+
+
+
+
+
+
+
+ 
160 75 
175 52 
180 43 
180 23 
165 57 
180 75 
180 62 
180 61 
170 59 
180 70 
0
 
CO 
170 80 
170 65 
180 70 
180 55 
170 60 
170 90 
180 70 
180 120 
170 65 
180 80 
-  
TABLE 9 GROUP 3 SUBJECTS (Placebo Application) 
PAIN DATA  
P.I. 
--------- 
Sex Age 
----  
Years 
0.A. 
-  
Test 
Time(pm)B/T 
AVAS AVAS 
AIT 
_ I 
E
 -4 00  0 cr  c- 00  CD CD  CD r-  C-  t-  0  CA  0 0  
0
1
 c- 00  
•1-1 
‘-4
  CO  N 	
N  0  '1  c
0
 N CO  
N
  cr) 0  0 0  eo CO  ! 
A/T pain I 
relief (hour. 
MP F 79 0.6 1.30 8.1 7.0 3 
GB F 68 0.6 12.30 4.6 1.3 24 
VW M 71 .10 2.30 -7.4 . 4.9 13 
HG M 57 3 12.00 6.0 0.6 1.5 
DP F 56 10 12.00 8.1 3.4 3 
BO F 59 5 2.30 8.5 5.7 3 
BR M 75 11 3.30 2.7 2.7 0 
DK F 48 3 2.00 4.9 0.0 24 
DM F 73 10 12.00 4.4 0.5 11 
WC F 68 10 2.30 1.7 0.0 24 
RC M 73 20 3.30 8.2 0.5 20 
JE M 86 40 2.00 7.8 4.1 24 
VE M 68 1 1.30 3.1 3.1 0 
JD F 73 1.5 1.30 4.3 2.1 24 
AL F 61 3 1.15 10.0 1.0 7 
EB F 81 5 1.30 8.8 8.8 0 
3M F 84 2 1.30 5.8 5.8 0 
MJ F 79 10 2.30 8.7 8.4 0 
AC M 63 3 3.00 5.3 1.6 2 
GL M 46 10 ' 12.30 8.3 0.0 20 
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TABLE 10 GROUP 3 SUBJECTS (Placebo Application) 
STIFFNESS DATA  
	
P.C
-1Q 	
0
 	
ts..1
A
 
 
CD  
A
 
C
A
  
A
 
C
A
  
m
  
p
4
  
>  1-"D  
<
C
 r14  
CD  
<C CD  
 . 
AVAS 
BIT 
AVAS 
A/T 
Diff 
(cm) 
A/T stiffness 
relief(hours) 
0.2 '0.2 0.0 0 
7.4 5.4 2.0 24 
7.6 4.9 2.9 7 
0.7 0.0 0.7 1.5 
3.6 0.0 3.6 7 
3.8 1.0 2.8 6.5 
0.0 0.0 0.0 0 
2.7 2.7 0.0 0 
8.2 2.3 0.0 24 
0.8 0.0 0.8 0 
4.5 0.1 4.4 20 
10.0 4.9 5.1 16 
0.2 0.0 0.2 0 
4.4 1.9 2.5 24 
10.0 10.0 0.0 0 
9.0 9.0 0.0 0 
0.0 0.0 0.0 0 
1.1 0.0 1.1 0 
7.9 1.0 6.9 5 
10.0 5.0 5.0 
 t_   
6 
- 
TABLE 11 cR0UP 3 SUBJECTS (Placebo Application) 
KNEE CIRCUMFERENCE DATA (in Centimeters) 
EA
  
CA  
a) 
a) 
s-
■ 
in
 0
  
0
 u
l  
L
c) 0
 	
O
LI
Lfl
O
U
O
1
U
U
O
LQ
1
U
L
U
O
 
• 	
• 	
• 	
• 	
. 	
. 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 	
• 
CO 00  OD aD  O
D
 u)  CD
 00  C
D
 0)  0
)  0
  OD  0
)  11) C )
 N44  
T
V
  N  0)  
0 	
00  
'41  
T
V
  CO  0)  0/  0)  0)  0)  0)  CO  
'11  
0
)
 cr 	
'11  CO  11  03  szr  
Circumference A/T Change 
38 0.5 
46.0 0.0 
42.0 1.0 
36.5 0.0 
38.0 0.5 
34.5 0.5 
38.5 0.5 
38.5 0.0 
35.5 1.0 
39.5 0.0 
38.5 0.5 
40.5 0.0 
38.0 0.0 
42.0 1.5 
45.0 0.5 
39.5 0.5 
34.5 0.0 
44.0 0.5 
36.0 - 0.5 
43.0 0.0 
TABLE 12 GROUP 3 SUBJECTS (Placebo Application) 87. 
RANGE OF MOVEMENT DATA (in degrees) 
P.I. Ext B/T 
+
1
1
+
 
 
+
 +
  +
 
+
  
+
  
+
  
CP
 0
 
00
 
,  
MP 180 
GB 180 
VW 165 
GV 180 
DP 180 
BO 180 
DK 180 
BR 180 
DM 180 
WC 180 
t•)  
0
 
00 
RC 170 
JE 175 
VE 180 
JD 180 
L 175 
EB 180 
180 
NJ 175 
, C 180 
GL 180 
APPENDIX 5  
Before test Stiffness Histograms as produced by SPSS - X Release 2.1 Prime 
Measured on AVAS in cms. ENTIRE GROUP Count 	Midpoint 	One symbol equals approx. 0.40 occurrences 9 .0 	*********************** 3 .5 ******** 4 	1.0 	********** 1 1.5 *** O 2.0 1 	2.5 	*** 2 3.0 ***** 1 	3.5 	*** 2 4.0 ***** 2 	4.5 	***** 3 5.0 ******** 2 	5.5 	***** O 6.0 1 	6.5 	*** 3 7.0 ******** 3 	7.5 	******** 5 8.0 ************* 2 	8.5 	***** 2 9.0 ***** 2 	9.5 	***** 12 10.0 ****************************** 0 	+ 	1 	+ 	4 	+ 	8 	+ 	12 	+ Valid cases = 60 	Histogram frequency 
FIG. 1 	Before test stiffness histograms for total group 
GROUP 1 Count 	Midpoint 	One symbol equals approx 0.10 occurrences 3 .0 	******* 1 	.5 *** O 1.0 1 	1.5 	*** O 2.0 O 2.5 2 	3.0 	***** O 3.5 O 4.0 O 4.5 O 5.0 1 	5.5 	*** O 6.0 O 6.5 3 	7.0 	******* O 7.5 1 	8.0 	*** 1 8.5 *** 1 	9.0 	*** O 9.5 6 	10.0 	*************** 0 	+ 	1 	+ 	2 	+ 	3 	+ Valid cases = 20 	Histogram frequency 
FIG. 2 Before test stiffness histograms Group 1 (High Rate TENS) 
89. GROUP 2 Count 	Midpoint 2 	.0 1 .5 2 	1.0 0 1.5 0 	2.0 0 2.5 0 	3.0 0 3.5 1 	4.0 0 4.5 3 	5.0 1 5.5 0 	6.0 1 6.5 0 	7.0 2 7.5 1 	8.0 1 8.5 0 	9.0 2 9.5 3 	10.0 
Valid cases = 20 
One symbol equals approx. 	0.1 occurrences ******************** ********** ******************** 
********** 
****************************** ********** 
********** 
******************** ********** ********** 
******************** ****************************** 
0 ....+....1....+....2....+....3....+....4.... Histogram frequency 
FIG. 3 	Before test Stiffness Histogram Group 2 (Low Rate TENS) 
GROUP 3 Count Midpoint 	One symbol equals approx. 0.10 Occurrences 4 	0.0 	**************************************** 1 0.5 ********** 2 	1.0 	******************** O 1.5 O 2.0 1 	2.5 	********** O 3.0 1 	3.5 	********** 1 4.0 ********** 2 	4.5 	******************** O 5.0 O 5.5 O 6.0 O 6.5 O 7.0 1 	7.5 	********** 3 8.0 ****************************** O 8.5 1 	9.0 	********** O 9.5 3 	10.0 	****************************** 
Valid cases = 20 	Histogram frequency 
FIG. 4 Before Test Stiffness Histogram Group 3 (Placebo Group) 
APPENDIX 6 
BEFORE TEST RANGE OF MOVEMENT HISTOGRAMS - Flexion/Extension measurements shown on Histograms produced by SPSS-X Release 2.1 Prime 
TOTAL GROUP FLEXION Count Midpoint 	One Symbol equals approx. 0.40 occurrences 1 	30 	*** O 36 1 	42 *.** 3 48 	********* 5 	54 ************* 7 60 ****************** 10 	66 	************************* 7 72 ****************** 12 	78 ****************************** 3 84 	********* 1 	90 *** 3 102 ********* 2 	108 	***** 1 114 *** O 120 O 126 O 132 2 	138 	***** O 144 1 	150 *** 
0 ....+....4....+....8....+....12...+....16...+... Valid cases = 60 	Histogram Frequency 
FIG 5(i) Before test Flexion Range of Movement Histogram Entire Group 
TOTAL GROUP EXTENSION 
Count Value 	One Symbol equals approx. 1.00 Occurrence 1 	160 3 165 *** 9 	170 	********* O 175 47 	180 *********************************************** 
0....+....10...+....20...+....30...+....40...+.... Valid cases = 60 	Histogram frequency 
FIG 5(ii) Before test Extension range of Movement Histogram Whole Group  
ArrhN1)1A b 	(cont) GROUP 1 FLEXION 
Count 	Midpoint 0 	35 1 41 1 	47 1 53 4 	59 3 65 2 	71 2 77 3 	83 0 89 0 	95 0 101 1 	107 1 113 0 	119 0 125 0 	131 0 137 0 	143 1 147 0 	155 
Valid Cases = 20 
One symbol equals approx. 	0.10 occurrences 
********** ********** ********** **************************************** ****************************** ******************** ******************** ****************************** 
********** ********** 
********** 
0....+....1....+....2....+....3....+....4....+.. Histogram Frequency 
FIG 6(i) Before test Flexion Range of Movement Group 1 (High Rate  TENS) 
GROUP 1 EXTENSION 
Count Value 	One symbol equals approx. 0.40 occurrences 1 	165 *** 3 170 ******** 1 	175 	*** 15 180 ************************************** 
0....+....4....+....8....+....12...+....16...+.. Valid Cases = 20 	Histogram frequency 
FIG 6(ii) Before test Extension Range of Movement Group 1 (High Rate  TENS) 
91 
Appendix ti 	tcont) GROUP 2 FLEXION 
Count 	Midpoint 0 	23 1 29 0 	35 0 41 0 	47 1 53 1 	59 4 65 2 	71 2 77 3 	83 1 89 3 	95 1 101 0 	107 0 113 0 	119 0 125 0 	131 1 137 0 	143 
Valid cases = 20 
One symbol equals approx. 	0.10 occurrences 
********** 
********** ********** **************************************** ******************** ******************** ****************************** ********** ****************************** ********** 
********** 
Histogram Frequency 
FIG 7(i) Before Test Flexion Range of Movement Histogram 
Group 2 (Low Rate TENS) 
GROUP 2 EXTENSION 
Count Value One Symbol equals approx. 	0.40 Occurrences 1 160 *** 1 165 *** 5 170 ************* 1 175 *** 12 180 ****************************** 0 	4 	8 	12 Valid Cases = 20 	Histogram Frequency 
FIG 7(ii) Before Test Extension Range of Movement Histogram 
Group 2 (Low Rate TENS) 
92. 
APPENDIX GROUP 3 FLEXION 
Count 
6 	(cont) 
Midpoint 
93. 
One symbol equals approx. 	0.10 Occurrences 
0 42 O. 47 2 52 ******************** 3 57 ****************************** 3 62 ****************************** 2 67 ******************** 3 72 ****************************** 77 ********** 2 82 ******************** 2 87 ******************** 0 92 0 97 0 102 
0 107 1 112 ********** 0 117 0 122 0 127 0 132 1 137 ********** 0 142 
Valid Cases = 20 	Histogram frequency 
FIG 8(i) Before test Flexion range of movement 
Group 3 (Placebo Group) 
GROUP 3 EXTENSION 
Count Value One symbol equals approx. 	0.40 Occurrences 1 165 *** 1 170 *** 2 175 ***** 16 180 ***************************************** 0....+....4....+....8....+....12...+....16... 
Valid Cases = 20 	Histogram frequency 
FIG 8(ii) Before test Extension range of movement 
Group 3 (Placebo Group) 
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